| | |
每个
个
共享 |
| |
合计
|
| ||||||
公开发行价
|
| | | $ | 18.00 | | | | | $ | 924,300,000 | | |
承保折扣和佣金(1)
|
| | | $ | 0.72 | | | | | $ | 36,972,000 | | |
未扣除费用的收益给我们
|
| | | $ | 17.28 | | | | | $ | 887,328,000 | | |
|
摩根大通
|
| |
高盛有限责任公司
|
| |
摩根士丹利
|
| | 巴克莱 | |
|
美国银行证券
|
| |
花旗集团
|
| |
风笛手
|
|
|
野村证券
|
| |
RBC资本市场
|
|
| | |
第
页
|
| |||
招股说明书摘要
|
| | | | 1 | | |
风险因素
|
| | | | 20 | | |
有关前瞻性陈述的特别说明
|
| | | | 58 | | |
收益使用情况
|
| | | | 60 | | |
股利政策
|
| | | | 61 | | |
大写
|
| | | | 62 | | |
未经审计的备考简明合并财务信息
|
| | | | 64 | | |
稀释
|
| | | | 69 | | |
管理层对财务状况和经营成果的讨论和分析
|
| | | | 71 | | |
业务
|
| | | | 93 | | |
管理
|
| | | | 122 | | |
高管和董事薪酬
|
| | | | 129 | | |
某些关系和关联方交易
|
| | | | 166 | | |
主要股东
|
| | | | 168 | | |
股本说明
|
| | | | 173 | | |
有资格未来出售的股票
|
| | | | 181 | | |
美国联邦所得税和遗产税对非美国持有者的某些后果
|
| | | | 184 | | |
承销(利益冲突)
|
| | | | 187 | | |
法律事务
|
| | | | 196 | | |
专家
|
| | | | 196 | | |
在哪里可以找到更多信息
|
| | | | 196 | | |
合并财务报表索引
|
| | | | F-1 | | |
| | |
截至2010年12月31日的年度
|
| |
三个月
截至3月31日 |
| ||||||||||||||||||||||||||||||
| | |
2020
|
| |
2019
|
| |
2018
|
| |
2020
|
| |
2021(6)
|
| |
2020
|
| ||||||||||||||||||
| | |
实际
|
| |
形式(1)
(未审核) |
| |
实际
|
| |||||||||||||||||||||||||||
| | |
(千)
|
| |||||||||||||||||||||||||||||||||
损益表和综合收益表(亏损)数据:
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
收入: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
保费收入
|
| | | | $ 1,180,338 | | | | | | $ 272,323 | | | | | | $ 127,122 | | | | | | $ 1,376,476 | | | | | | $ 860,631 | | | | | | $ 190,737 | | |
服务收入
|
| | | | 18,514 | | | | | | — | | | | | | — | | | | | | 18,514 | | | | | | 8,438 | | | | | | 4,820 | | |
投资收益
|
| | | | 8,468 | | | | | | 8,350 | | | | | | 3,510 | | | | | | 8,493 | | | | | | 5,489 | | | | | | 3,009 | | |
总收入
|
| | | | 1,207,320 | | | | | | 280,673 | | | | | | 130,632 | | | | | | 1,403,483 | | | | | | 874,558 | | | | | | 198,566 | | |
运营成本: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
医疗费用
|
| | | | 1,047,300 | | | | | | 224,387 | | | | | | 96,407 | | | | | | 1,233,725 | | | | | | 684,570 | | | | | | 130,615 | | |
运营成本
|
| | | | 409,334 | | | | | | 180,489 | | | | | | 95,836 | | | | | | 432,718 | | | | | | 208,240 | | | | | | 74,444 | | |
折旧摊销
|
| | | | 8,289 | | | | | | 1,134 | | | | | | 1,030 | | | | | | 10,623 | | | | | | 4,581 | | | | | | 787 | | |
总运营成本
|
| | | | 1,464,923 | | | | | | 406,010 | | | | | | 193,273 | | | | | | 1,677,066 | | | | | | 897,391 | | | | | | 205,846 | | |
营业亏损
|
| | | | (248,442) | | | | | | (125,337) | | | | | | (62,641) | | | | | | (273,583) | | | | | | (22,833) | | | | | | (7,280) | | |
利息支出
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 546 | | | | | | — | | |
所得税前亏损
|
| | | | (257,603) | | | | | | (125,337) | | | | | | (62,641) | | | | | | (273,583) | | | | | | (23,379) | | | | | | (7,280) | | |
所得税(福利)费用
|
| | | | (9,161) | | | | | | — | | | | | | — | | | | | | (9,161) | | | | | | 1,166 | | | | | | — | | |
净亏损
|
| | | | (248,442) | | | | | | (125,337) | | | | | | (62,641) | | | | | | (264,422) | | | | | | (24,545) | | | | | | (7,280) | | |
其他综合收益(亏损): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
未实现投资控股
在 期间产生的收益(亏损) 年 |
| | | | 1,556 | | | | | | 1,211 | | | | | | 72 | | | | | | 1,556 | | | | | | (980) | | | | | | 890 | | |
净亏损中包含的投资收益(亏损)的重新分类调整较少
|
| | | | 112 | | | | | | 38 | | | | | | (17) | | | | | | 112 | | | | | | 62 | | | | | | (61) | | |
其他综合收益(亏损)合计
|
| | | | 1,444 | | | | | | 1,173 | | | | | | 89 | | | | | | 1,444 | | | | | | (1,042) | | | | | | 951 | | |
全面亏损
|
| | | | (246,998) | | | | | | (124,164) | | | | | | (62,552) | | | | | | (262,978) | | | | | | (25,587) | | | | | | (6,329) | | |
应占综合亏损
转让给非控股权益 |
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (617) | | | | | | — | | |
应占综合亏损
致光明健康集团有限公司 普通股股东 |
| | | | $ (246,998) | | | | | | $ (124,164) | | | | | | $ (62,552) | | | | | | $ (262,978) | | | | | | $ (26,204) | | | | | | $ (6,329) | | |
非GAAP指标: | | | | | | | | | | | | | | | | | | | | | | | | | | | | ||||||||||
调整后的EBITDA(2)
|
| | | | $ (238,912) | | | | | | $ (121,091) | | | | | | $ (61,354) | | | | | | $ (252,558) | | | | | | $ (9,584) | | | | | | $ (3,855) | | |
| | |
截至2010年12月31日的年度
|
| |
截止三个月
3月31日 |
| | ||||||||||||||||||||||||||||||||||||||
| | |
2020
|
| |
2019
|
| |
2018
|
| |
2020
|
| |
2021(6)
|
| |
2020
|
| |
2021
|
| | |||||||||||||||||||||||
| | |
实际
|
| |
形式
(未经审计)(3)(4) |
| |
实际
|
| |
形式
(未经审计)(3)(4) |
| | ||||||||||||||||||||||||||||||||
| | |
(千元,每股除外)
|
| | | | |||||||||||||||||||||||||||||||||||||||
每股数据: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ||
普通股股东每股基本和摊薄净亏损
|
| | | | $ (1.82) | | | | | | $ (0.93) | | | | | | $ (0.47) | | | | | | $ (0.55) | | | | | | $ (0.18) | | | | | | $ (0.05) | | | | | | $ (0.05) | | | | ||
加权平均已发行普通股用于计算普通股股东应占每股净亏损,包括基本亏损和摊薄亏损
|
| | | | 136,193 | | | | | | 134,486 | | | | | | 131,975 | | | | | | 476,818 | | | | | | 140,175 | | | | | | 137,125 | | | | | | 557,659 | | | |
| | |
截至2010年12月31日的年度
|
| |
截止三个月
3月31日 |
| ||||||||||||||||||||||||
| | |
2020
|
| |
2019
|
| |
2018
|
| |
2021
|
| |
2020
|
| |||||||||||||||
| | |
(千)
|
| |||||||||||||||||||||||||||
现金流数据: | | | | | | | | | | | | | | | | | | | | | | ||||||||||
净现金提供人(使用于): | | | | | | | | | | | | | | | | | | | | | | ||||||||||
经营活动
|
| | | $ | (57,238) | | | | | $ | (8,208) | | | | | $ | (27,034) | | | | | $ | 343,603 | | | | | $ | 82,286 | | |
投资活动
|
| | | | (689,742) | | | | | | (94,643) | | | | | | (6,940) | | | | | | (56,275) | | | | | | (338,359) | | |
融资活动
|
| | | | 712,441 | | | | | | 424,060 | | | | | | 203,057 | | | | | | 200,234 | | | | | | 13 | | |
| | |
截至2021年3月31日
|
| |||||||||||||||
| | |
实际(6)
|
| |
形式(4)
(未审核) |
| |
形式为
调整后(5) (未审核) |
| |||||||||
| | |
(千)
|
| |||||||||||||||
资产负债表数据: | | | | | | | | | | | | | | | | | | | |
现金和现金等价物
|
| | | $ | 975,933 | | | | | $ | 975,933 | | | | | $ | 1,659,418 | | |
总资产
|
| | | | 2,488,118 | | | | | | 2,488,118 | | | | | | 3,168,771 | | |
总债务
|
| | | | 200,000 | | | | | | 200,000 | | | | | | — | | |
总负债
|
| | | | 1,231,556 | | | | | | 1,231,556 | | | | | | 1,031,556 | | |
股东权益总额(亏损)
|
| | | | (519,807) | | | | | | 1,216,345 | | | | | | 2.096,998 | | |
| | |
截至2010年12月31日的年度
|
| |
截至3月31日的三个月
|
| ||||||||||||||||||||||||||||||
| | |
2020
|
| |
2019
|
| |
2018
|
| |
2020
|
| |
2021
|
| |
2020
|
| ||||||||||||||||||
| | |
实际
|
| |
形式
(未审核) |
| |
实际
|
| |||||||||||||||||||||||||||
| | |
(千)
|
| |||||||||||||||||||||||||||||||||
净亏损(6)
|
| | | $ | (248,442) | | | | | $ | (125,337) | | | | | $ | (62,641) | | | | | $ | (264,422) | | | | | $ | (24,545) | | | | | $ | (7,280) | | |
利息支出
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 546 | | | | | | — | | |
所得税(福利)费用
|
| | | | (9,161) | | | | | | — | | | | | | — | | | | | | (9,161) | | | | | | 1,166 | | | | | | — | | |
折旧摊销
|
| | | | 8,289 | | | | | | 1,134 | | | | | | 1,030 | | | | | | 10,623 | | | | | | 4,581 | | | | | | 787 | | |
交易成本(A)
|
| | | | 4,950 | | | | | | 1,248 | | | | | | — | | | | | | 4,950 | | | | | | 2,020 | | | | | | 1,695 | | |
基于股份的薪酬费用(B)(6)
|
| | | | 5,452 | | | | | | 1,864 | | | | | | 257 | | | | | | 5,452 | | | | | | 5,176 | | | | | | 943 | | |
或有对价公允价值变动(C)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 1,472 | | | | | | — | | |
调整后的EBITDA
|
| | | $ | (238,912) | | | | | $ | (121,091) | | | | | $ | (61,354) | | | | | $ | (252,558) | | | | | $ | (9,584) | | | | | $ | (3,855) | | |
| | |
年终
12月31日 2020 |
| |
三个月
已结束 3月31日 2021 |
| ||||||
| | |
(单位为千,
除外
每股金额) |
| |||||||||
分子: | | | | | | | | | |||||
普通股股东应占净亏损(6)
|
| | | $ | (264,422) | | | | | $ | (25,162) | | |
分母: | | | | | | | | | |||||
加权平均流通股数,用于计算普通股股东应占每股净亏损,基本亏损和摊薄亏损
|
| | | | 136,193 | | | | | | 140,175 | | |
预计调整,以反映假设的优先股转换
|
| | | | 340,625 | | | | | | 417,484 | | |
预计加权-用于计算预计基本和摊薄每股预计净亏损的平均流通股数量
|
| | | | 476,818 | | | | | | 557,659 | | |
预计每股净亏损,基本和摊薄
|
| | | $ | (0.55) | | | | | $ | (0.05) | | |
| | |
截至2021年3月31日
|
| |||||||||||||||
| | |
实际(2)
|
| |
形式
|
| |
形式
调整后的 |
| |||||||||
| | |
(单位为千,不包括股票和面值)
|
| |||||||||||||||
现金和现金等价物
|
| | | $ | 975,933 | | | | | $ | 975,933 | | | | | $ | 1,659,418 | | |
债务: | | | | | | | | | | | | | | | | | | | |
总债务(1)
|
| | | | 200,000 | | | | | | 200,000 | | | | | | — | | |
可赎回股权: | | | | | | | | | | | | | | | | | | | |
可赎回的非控股权益
|
| | | | 40,217 | | | | | | 40,217 | | | | | | 40,217 | | |
优先股,面值0.0001美元;168,065,332股
授权、实际发行的股票为165,664,947股, 已发行实际授权的168,065,332股, 预计,没有发行和流通股,预计, 100,000,000股授权,调整后形式,无 已发行和已发行股票,调整后形式 |
| | | | 1,736,152 | | | | | | — | | | | | | — | | |
股东权益(亏损): | | | | | | | | | | | | | | | | | | | |
普通股,面值0.0001美元;674,593,725股授权,实际,142,323,510股已发行和已发行,实际,674,593,725股授权,预计,564,020,214股已发行和已发行,预计,3,000,000,000股授权,预计
调整后,已发行和已发行股票615,370,214股,调整后预计数量 |
| | | | 14 | | | | | | 56 | | | | | | 61 | | |
新增实收资本
|
| | | | 19,946 | | | | | | 1,756,056 | | | | | | 2,636,704 | | |
累计亏损
|
| | | | (541,151) | | | | | | (541,151) | | | | | | (541,151) | | |
累计其他综合收益(亏损)
|
| | | | 1,384 | | | | | | 1,384 | | | | | | 1,384 | | |
股东权益总额(亏损)
|
| | | $ | (519,807) | | | | | $ | 1,216,345 | | | | | $ | 2,096,998 | | |
总市值
|
| | | $ | 1,456,562 | | | | | $ | 1,456,562 | | | | | $ | 2,137,215 | | |
| | |
明亮
健康 历史 |
| |
全新品牌
日期为 调整后的 (注3) |
| |
交易
会计 调整 (注4) |
| |
明亮
Health Pro 格式 组合 |
| ||||||||||||
收入
|
| | | | $ 1,207,320 | | | | | | $ 196,163 | | | | | | | | | | | | $1,403,483 | | |
运营成本: | | | | | | | | | | | | | | | | | | | | | | | | | |
医疗费用
|
| | | | 1,047,300 | | | | | | 186,425 | | | | | | | | | | | | 1,233,725 | | |
运营成本
|
| | | | 409,334 | | | | | | 23,416 | | | | | | (32)(a) | | | | | | 432,718 | | |
折旧摊销
|
| | | | 8,289 | | | | | | 629 | | | | | | 1,705(b) | | | | | | 10,623 | | |
总运营成本
|
| | | | 1,464,923 | | | | | | 210,470 | | | | | | | | | | | | 1,677,066 | | |
营业亏损
|
| | | | (257,603) | | | | | | (14,307) | | | | | | | | | | | | (273,583) | | |
利息费用净额
|
| | | | — | | | | | | (565) | | | | | | 565(c) | | | | | | — | | |
所得税前亏损
|
| | | | (257,603) | | | | | | (14,872) | | | | | | | | | | | | (273,583) | | |
所得税(福利)费用
|
| | | | (9,161) | | | | | | — | | | | |
|
(d)
|
| | | | | (9,161) | | |
净亏损
|
| | | | $ (248,442) | | | | | | $ (14,872) | | | | | | | | | | | | $ (264,422) | | |
普通股股东应占每股基本亏损和摊薄亏损以及每股预计亏损
|
| | | | $ (1.82) | | | | | | | | | | | | | | | | | | $ (0.55)(e) | | |
加权平均流通股数量和
形式加权-平均使用股份数 计算可归因于 的每股净亏损 普通股股东,基本股东和稀释股东 |
| | | | 136,193 | | | | | | | | | | | | | | | | | | 476,818 | | |
| | |
品牌新日
四个月 已结束 历史 2020年4月30日 |
| |
调整
以符合 演示文稿 |
| |
全新品牌
第四天 个月截止 2020年4月30日 调整后的 |
| |||||||||
(千) | | | | | | | | | | | | | | | | | | | |
总收入*
|
| | | | $ 196,163 | | | | | | $ — | | | | | | $ 196,163 | | |
运营成本: | | | | | | | | | | | | | | | | | | | |
医疗费用*
|
| | | | — | | | | | | 186,425(i) | | | | | | 186,425 | | |
运营成本*
|
| | | | — | | | | | | 23,416 (Ii) | | | | | | 23,416 | | |
医疗服务
|
| | | | 186,425 | | | | | | (186,425)(i) | | | | | | — | | |
营销、一般和行政费用
|
| | | | 16,740 | | | | | | (16,740)(Ii) | | | | | | — | | |
工资福利
|
| | | | 6,676 | | | | | | (6,676)(Ii) | | | | | | — | | |
折旧和摊销*
|
| | | | 629 | | | | | | — | | | | | | 629 | | |
总运营成本
|
| | | | 210,470 | | | | | | — | | | | | | 210,470 | | |
营业收入(亏损)
|
| | | | (14,307) | | | | | | — | | | | | | (14,307) | | |
利息费用净额
|
| | | | (565) | | | | | | — | | | | | | (565) | | |
所得税前亏损*
|
| | | | (14,872) | | | | | | — | | | | | | (14,872) | | |
所得税(福利)费用
|
| | | | — | | | | | | — | | | | | | — | | |
净亏损
|
| | | | $ (14,872) | | | | | | $ — | | | | | | $ (14,872) | | |
| | |
预计
公允价值 |
| |
预计
使用寿命 (单位:年) |
| |
折旧和
摊销 费用 这4个月 截至4月 30, 2020 |
| |||||||||
(千) | | | | | | | | | | | | | | | | | | | |
财产、设备和大写软件
|
| | | $ | 4,375 | | | | | | 3.7 | | | | | $ | 394 | | |
成员关系
|
| | | | 46,900 | | | | | | 12 | | | | | | 1,304 | | |
商品名称
|
| | | | 25,600 | | | | | | 15 | | | | | | 569 | | |
提供商网络
|
| | | | 2,000 | | | | | | 10 | | | | | | 67 | | |
新折旧及摊销费用
|
| | | | | | | | | | | | | | | | 2,334 | | |
取消历史品牌新日折旧和摊销费用
|
| | | | | | | | | | | | | | | | (629) | | |
预计折旧和摊销调整
|
| | | | | | | | | | | | | | | $ | 1,705 | | |
| | |
用于
年终 2020年12月31日 |
| |||
(千元,每股除外) | | | | | | | |
分子: | | | | | | | |
普通股股东预计净亏损
|
| | | | $ (264,422) | | |
分母: | | | | | | | |
加权平均流通股数,用于计算普通股股东应占每股净亏损,基本亏损和摊薄亏损
|
| | | | 136,193 | | |
预计调整,以反映假设的优先股转换
|
| | | | 340,625 | | |
预计加权-用于计算预计基本和摊薄每股预计净亏损的平均流通股数量
|
| | | | 476,818 | | |
预计每股净亏损,基本和摊薄
|
| | | | $ (0.55) | | |
|
每股首次公开募股价格
|
| |
|
| | | $ | 18.00 | | | |||
|
生效前截至2021年3月31日的每股有形账面净亏损
提供服务 |
| | | $ | (7.14) | | | | | | | | |
|
可归因于转换已发行优先股的每股有形账面净值增加
|
| | | | 8.42 | | | | |||||
|
可归因于新投资者购买此次发行股票的每股有形账面净值增加
|
| | | | 1.32 | | | | |||||
|
调整后的每股有形账面净值将使本次发售生效,并将我们所有已发行的优先股自动转换为421,696,704股普通股
|
| | | | | | | | | | 2.60 | | |
|
此次发行向新投资者每股摊薄
|
| | | | | | | | | $ | 15.40 | | |
| | |
购买的股票
|
| |
总体考虑
|
| |
平均
价格 共享 |
| |||||||||||||||||||||
| | |
号码
|
| |
百分比
|
| |
金额
|
| |
百分比
|
| ||||||||||||||||||
| | |
(百万)
|
| | | | | | | |
(百万)
|
| | | | |||||||||||||||
现有股东(1)
|
| | | | 564.0 | | | | | | 92% | | | | | $ | 1,743.3(2) | | | | | | 65% | | | | | $ | 3.09 | | |
新投资者
|
| | | | 51.4 | | | | | | 8% | | | | | | 924.3 | | | | | | 35% | | | | | | 18.00 | | |
合计
|
| | | | 615.4 | | | | | | 100% | | | | | | 2,667.6 | | | | | | 100% | | | | | | 4.33 | | |
|
优先股转换后可发行的普通股
|
| | | | 421,696,704 | | |
|
已发行和已发行普通股
|
| | | | 142,323,510 | | |
|
现有股东购买的普通股合计
|
| | | | 564,020,214 | | |
| | |
截至2010年12月31日的年度
|
| |
截止三个月
3月31日 |
| ||||||||||||||||||||||||
| | |
2020
|
| |
2019
|
| |
2018
|
| |
2021
|
| |
2020
|
| |||||||||||||||
| | |
(千美元)
|
| |||||||||||||||||||||||||||
服务的光明医疗消费者 | | | | | | | | | | | | | | | | | | | | | | ||||||||||
商业(1)
|
| | | | 145,459 | | | | | | 54,782 | | | | | | 22,114 | | | | | | 481,958 | | | | | | 152,263 | | |
联邦医疗保险优势
|
| | | | 61,663 | | | | | | 4,146 | | | | | | 2,262 | | | | | | 67,567 | | | | | | 5,784 | | |
NeueHealth患者 | | | | | | | | | | | | | | | | | | | | | | ||||||||||
基于价值的护理患者
|
| | | | 21,126 | | | | | | — | | | | | | — | | | | | | 30,890 | | | | | | 20,294 | | |
净亏损(2)
|
| | | | $ (248,442) | | | | | | $ (125,337) | | | | | | $ (62,641) | | | | | | $ (24,545) | | | | | | $ (7,280) | | |
调整后的EBITDA(3)
|
| | | | $ (238,912) | | | | | | $ (121,091) | | | | | | $ (61,354) | | | | | | $ (9,584) | | | | | | $ (3,855) | | |
| | |
截至2010年12月31日的年度
|
| |
截至3月31日的三个月
|
| ||||||||||||||||||||||||
(千)
|
| |
2020
|
| |
2019
|
| |
2018
|
| |
2021
|
| |
2020
|
| |||||||||||||||
净亏损(A)
|
| | | | $ (248,442) | | | | | | $ (125,337) | | | | | | $ (62,641) | | | | | | $ (24,545) | | | | | | $ (7,280) | | |
利息支出
|
| | | | — | | | | | | — | | | | | | — | | | | | | 546 | | | | | | — | | |
所得税(福利)费用
|
| | | | (9,161) | | | | | | — | | | | | | — | | | | | | 1,166 | | | | | | — | | |
折旧摊销
|
| | | | 8,289 | | | | | | 1,134 | | | | | | 1,030 | | | | | | 4,581 | | | | | | 787 | | |
交易成本(B)
|
| | | | 4,950 | | | | | | 1,248 | | | | | | — | | | | | | 2,020 | | | | | | 1,695 | | |
基于股份的薪酬费用(A)(C)
|
| | | | 5,452 | | | | | | 1,864 | | | | | | 257 | | | | | | 5,176 | | | | | | 943 | | |
或有对价公允价值变动(D)
|
| | | | — | | | | | | — | | | | | | — | | | | | | 1,472 | | | | | | — | | |
调整后的EBITDA
|
| | | | $ (238,912) | | | | | | $ (121,091) | | | | | | $ (61,354) | | | | | | $ (9,584) | | | | | | $ (3,855) | | |
| | |
截至3月31日的三个月
|
| |||||||||
合并损益表和经营数据:
|
| |
2021(3)
|
| |
2020
|
| ||||||
| | |
(千元,百分比除外)
|
| |||||||||
收入: | | | | | | | | | | | | | |
保费收入
|
| | | $ | 860,631 | | | | | $ | 190,737 | | |
服务收入
|
| | | | 8,438 | | | | | | 4,820 | | |
投资收益
|
| | | | 5,489 | | | | | | 3,009 | | |
总收入
|
| | | | 874,558 | | | | | | 198,566 | | |
运营成本: | | | | | | | | | | | | | |
医疗费用
|
| | | | 684,570 | | | | | | 130,615 | | |
运营成本
|
| | | | 208,240 | | | | | | 74,444 | | |
折旧摊销
|
| | | | 4,581 | | | | | | 787 | | |
总运营成本
|
| | | | 897,391 | | | | | | 205,846 | | |
营业亏损
|
| | | | (22,833) | | | | | | (7,280) | | |
利息支出
|
| | | | 546 | | | | | | — | | |
所得税前亏损
|
| | | | (23,379) | | | | | | (7,280) | | |
所得税(福利)费用
|
| | | | 1,166 | | | | | | — | | |
净亏损
|
| | | | (24,545) | | | | | | (7,280) | | |
可归因于非控股权益的净收益
|
| | | | (617) | | | | | | — | | |
光明健康集团普通股净亏损
股东 |
| | | $ | (25,162) | | | | | $ | (7,280) | | |
调整后的EBITDA
|
| | | $ | (9,584) | | | | | $ | (3,855) | | |
医疗费用比率(MCR)(1)
|
| | | | 79.5% | | | | | | 68.5% | | |
运营成本比率(2)
|
| | | | 23.8% | | | | | | 37.5% | | |
| | |
截至3月31日的三个月
|
| |||||||||
损益表和经营数据:
|
| |
2021(2)
|
| |
2020
|
| ||||||
| | |
(千元,百分比除外)
|
| |||||||||
光明医疗保健: | | | | | | | | | | | | | |
商业保费收入(1)
|
| | | $ | 621,056 | | | | | $ | 175,562 | | |
Medicare Advantage保费收入
|
| | | | 220,869 | | | | | | 13,171 | | |
投资收益
|
| | | | 1,246 | | | | | | 3,009 | | |
总收入
|
| | | | 843,171 | | | | | | 191,742 | | |
运营成本: | | | | | | | | | | | | | |
医疗费用
|
| | | | 675,056 | | | | | | 130,615 | | |
运营成本
|
| | | | 189,973 | | | | | | 66,975 | | |
折旧摊销
|
| | | | 2,357 | | | | | | 262 | | |
总运营成本
|
| | | | 867,386 | | | | | | 197,852 | | |
营业亏损
|
| | | $ | (24,215) | | | | | $ | (6,110) | | |
医疗费用比率(MCR)
|
| | | | 80.2% | | | | | | 69.2% | | |
| | |
截至3月31日的三个月
|
| |||||||||
损益表和经营数据:
|
| |
2021(1)
|
| |
2020
|
| ||||||
| | |
(千)
|
| |||||||||
NeueHealth | | | | | | | | | | | | | |
保费收入
|
| | | $ | 28,674 | | | | | $ | 2,004 | | |
服务收入
|
| | | | 15,622 | | | | | | 7,527 | | |
投资收益
|
| | | | 4,243 | | | | | | — | | |
总收入
|
| | | | 48,539 | | | | | | 9,531 | | |
运营成本: | | | | | | | | | | | | | |
医疗费用
|
| | | | 19,482 | | | | | | — | | |
运营成本
|
| | | | 25,451 | | | | | | 10,176 | | |
折旧摊销
|
| | | | 2,224 | | | | | | 525 | | |
总运营成本
|
| | | | 47,157 | | | | | | 10,701 | | |
营业收入(亏损)
|
| | | $ | 1,382 | | | | | $ | (1,170) | | |
| | |
截至2010年12月31日的年度
|
| |||||||||||||||
合并损益表和经营数据:
|
| |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
| | |
(千元,百分比除外)
|
| |||||||||||||||
收入: | | | | | | | | | | | | | | | | | | | |
保费收入
|
| | | | $ 1,180,338 | | | | | | $ 272,323 | | | | | | $ 127,122 | | |
服务收入
|
| | | | 18,514 | | | | | | — | | | | | | — | | |
投资收益
|
| | | | 8,468 | | | | | | 8,350 | | | | | | 3,510 | | |
总收入
|
| | | | 1,207,320 | | | | | | 280,673 | | | | | | 130,632 | | |
运营成本: | | | | | | | | | | | | | | | | | | | |
医疗费用
|
| | | | 1,047,300 | | | | | | 224,387 | | | | | | 96,407 | | |
运营成本
|
| | | | 409,334 | | | | | | 180,489 | | | | | | 95,836 | | |
折旧摊销
|
| | | | 8,289 | | | | | | 1,134 | | | | | | 1,030 | | |
总运营成本
|
| | | | 1,464,923 | | | | | | 406,010 | | | | | | 193,273 | | |
所得税前亏损
|
| | | | (257,603) | | | | | | (125,337) | | | | | | (62,641) | | |
所得税(福利)费用
|
| | | | (9,161) | | | | | | — | | | | | | — | | |
净亏损
|
| | | | $ (248,442) | | | | | | $ (125,337) | | | | | | $ (62,641) | | |
调整后的EBITDA
|
| | | | $ (238,912) | | | | | | $ (121,091) | | | | | | $ (61,354) | | |
医疗费用比率(MCR)(1)
|
| | | | 88.7% | | | | | | 82.4% | | | | | | 75.8% | | |
运营成本比率(2)
|
| | | | 33.9% | | | | | | 64.3% | | | | | | 73.4% | | |
| | |
截至2010年12月31日的年度
|
| |||||||||||||||
损益表和经营数据:
|
| |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
| | |
(千元,百分比除外)
|
| |||||||||||||||
光明医疗保健: | | | | | | | | | | | | | | | | | | | |
商业保费收入(1)
|
| | | | $ 692,433 | | | | | | $ 236,290 | | | | | | $ 111,412 | | |
Medicare Advantage保费收入
|
| | | | 480,112 | | | | | | 36,033 | | | | | | 15,710 | | |
投资收益
|
| | | | 8,468 | | | | | | 8,350 | | | | | | 3,510 | | |
总收入
|
| | | | 1,181,013 | | | | | | 280,673 | | | | | | 130,632 | | |
运营成本: | | | | | | | | | | | | | | | | | | | |
医疗费用
|
| | | | 1,047,300 | | | | | | 224,387 | | | | | | 96,407 | | |
运营成本
|
| | | | 376,215 | | | | | | 180,489 | | | | | | 95,836 | | |
折旧摊销
|
| | | | 6,394 | | | | | | 1,134 | | | | | | 1,030 | | |
总运营成本
|
| | | | 1,429,909 | | | | | | 406,010 | | | | | | 193,273 | | |
所得税前亏损
|
| | | | $ (248,896) | | | | | | $ (125,337) | | | | | | $ (62,641) | | |
医疗费用比率(MCR)
|
| | | | 89.3% | | | | | | 82.4% | | | | | | 75.8% | | |
| | |
截至2010年12月31日的年度
|
| |||||||||||||||
损益表和经营数据:
|
| |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
| | |
(千)
|
| |||||||||||||||
NeueHealth | | | | | | | | | | | | | | | | | | | |
服务收入
|
| | | | $ 29,354 | | | | | | $ — | | | | | | $ — | | |
保费收入
|
| | | | 7,793 | | | | | | — | | | | | | — | | |
总收入
|
| | | | $ 37,147 | | | | | | $ — | | | | | | $ — | | |
运营成本: | | | | | | | | | | | | | | | | | | | |
运营成本
|
| | | | 43,959 | | | | | | — | | | | | | — | | |
折旧摊销
|
| | | | 1,895 | | | | | | — | | | | | | — | | |
总运营成本
|
| | | | 45,854 | | | | | | — | | | | | | — | | |
所得税前亏损
|
| | | | $ (8,707) | | | | | | $ — | | | | | | $ — | | |
| | |
截至3月31日的三个月
|
| | | | |||||||||
| | |
2021
|
| |
2020
|
| | ||||||||
| | |
(千)
|
| | |||||||||||
经营活动提供的净现金
|
| | | $ | 343,603 | | | | | $ | 82,286 | | | | ||
投资活动使用的净现金
|
| | | | (56,275) | | | | | | (338,359) | | | | ||
融资活动提供的净现金
|
| | | | 200,234 | | | | | | 13 | | | | ||
现金及现金等价物净增(减)
|
| | | | 487,562 | | | | | | (256,060) | | | | ||
期初现金和现金等价物
|
| | | | 488,371 | | | | | | 522,910 | | | | ||
期末现金和现金等价物
|
| | | $ | 975,933 | | | | | $ | 266,850 | | | |
| | |
截至2010年12月31日的年度
|
| |||||||||||||||
| | |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
| | |
(千)
|
| |||||||||||||||
经营活动使用的净现金
|
| | | | $ (57,238) | | | | | | $ (8,208) | | | | | | $ (27,034) | | |
投资活动使用的净现金
|
| | | | (689,742) | | | | | | (94,643) | | | | | | (6,940) | | |
融资活动提供的净现金
|
| | | | 712,441 | | | | | | 424,060 | | | | | | 203,057 | | |
现金和现金等价物净增长
|
| | | | (34,539) | | | | | | 321,209 | | | | | | 169,083 | | |
年初的现金和现金等价物
|
| | | | 522,910 | | | | | | 201,701 | | | | | | 32,618 | | |
年终现金和现金等价物
|
| | | | $ 488,371 | | | | | | $ 522,910 | | | | | | $ 201,701 | | |
完井系数
(减少)因素增加 |
| |
增加(减少)
应付医疗费用 |
| |||
| | |
(千)
|
| |||
(3.00)%
|
| | | | $ 25,826 | | |
(2.00)%
|
| | | | 17,042 | | |
(1.00)%
|
| | | | 8,435 | | |
1.00%
|
| | | | (8,268) | | |
2.00%
|
| | | | (16,374) | | |
3.00%
|
| | | | (24,322) | | |
名称
|
| |
年龄
|
| |
职位
|
|
G.Mike Mikan | | |
50
|
| | 首席执行官、总裁兼董事 | |
凯瑟琳·R·史密斯 | | |
57
|
| | 首席财务和行政官 | |
萨姆·K·斯里瓦斯塔瓦 | | |
53
|
| | NeueHealth首席执行官 | |
托马斯·瓦尔迪瓦 | | |
59
|
| | 首席健康和股票官 | |
基思·尼尔森 | | |
57
|
| | 总法律顾问兼公司秘书 | |
西蒙·辛德尔曼 | | |
58
|
| | 光明医疗集团首席执行官 | |
罗伯特·J·希伊 | | |
63
|
| | 董事会主席 | |
小凯德里克·D·阿德金斯(Kedrick D.Adkins Jr.) | | |
68
|
| | 导演 | |
娜奥米·艾伦 | | |
47
|
| | 导演 | |
杰弗里·福利克 | | |
73
|
| | 导演 | |
琳达·古登 | | |
68
|
| | 导演 | |
杰弗里·R·伊梅尔特 | | |
65
|
| | 导演 | |
曼努埃尔·卡德雷 | | |
55
|
| | 导演 | |
斯蒂芬·克劳斯 | | |
44
|
| | 导演 | |
穆罕默德·马赫祖米 | | |
41
|
| | 导演 | |
阿代尔·纽荷尔 | | |
42
|
| | 导演 | |
公司名称
|
| |
业务细分
|
|
Adobe Inc. | | | 软件 | |
Allscript Healthcare Solutions,Inc. | | | HC技术 | |
美国肾脏协会控股公司 | | | HC提供商和服务 | |
AMN Healthcare Services Inc. | | | HC提供商和服务 | |
AthenaHealth Inc.* | | | HC技术 | |
阿卡迪亚医疗保健 | | | HC提供商和服务 | |
Cerner Corporation | | | HC技术 | |
DaVita Inc. | | | HC提供商和服务 | |
包括健康公司 | | | HC提供商和服务 | |
enVision Healthcare Corporation* | | | HC提供商和服务 | |
Evolent Health,Inc. | | | HC提供商和服务 | |
Gartner,Inc. | | | IT服务 | |
Intuit Inc. | | | 软件 | |
生命点健康* | | | HC提供商和服务 | |
麦哲伦健康公司 | | | HC提供商和服务 | |
Mednax,Inc. | | | HC提供商和服务 | |
Molina Healthcare Inc. | | | HC提供商和服务 | |
Owens&Minor,Inc. | | | HC提供商和服务 | |
Paychex,Inc. | | | IT服务 | |
VMWare,Inc. | | | 软件 | |
Workday,Inc. | | | 软件 | |
薪酬要素
|
| |
说明
|
| |
目标
|
|
基本工资
|
| | 固定薪酬 | | | 提供有竞争力的固定水平的现金薪酬,以吸引和留住有才华、有技能的高管 | |
年度现金红利
|
| | 在考虑财务和个人业绩后确定的可自由支配年度现金奖金 | | | 留住并激励高管实现或超过财务目标和公司目标 | |
股票期权
|
| | 基于继续受雇而归属的股权挂钩薪酬 | | | 期权的价值与随时间推移交付给股东的价值增值直接相关,从而使我们高管的利益与我们股东的利益保持一致 | |
员工福利和津贴
|
| | 参与所有基础广泛的员工健康和福利计划以及退休计划 | | | 在竞争激烈的人才市场中,通过提供全面的有竞争力的福利方案,帮助留住关键高管 | |
名称
|
| |
财政
年终 2019年基础版 工资($) |
| |
财政
年终 2020基数 工资($)(1) |
| |
百分比
增加(%) |
| |||||||||
G.Mike Mikan
|
| | | | 300,000 | | | | | | 600,000 | | | | | | 100 | | |
凯西·史密斯
|
| | | | — | | | | | | 450,000 | | | | | | — | | |
罗伯特·希伊
|
| | | | 300,000 | | | | | | 600,000 | | | | | | 100 | | |
基思·尼尔森
|
| | | | — | | | | | | 400,000 | | | | | | — | | |
西蒙·辛德尔曼
|
| | | | 300,000 | | | | | | 400,000 | | | | | | 33 | | |
萨姆·斯里瓦斯塔瓦
|
| | | | 300,000 | | | | | | 400,000 | | | | | | 33 | | |
名称
|
| |
2021基座
工资($) |
| |||
G.Mike Mikan
|
| | | | 1,300,000 | | |
凯西·史密斯
|
| | | | 650,000 | | |
基思·尼尔森
|
| | | | 550,000 | | |
西蒙·辛德尔曼
|
| | | | 575,000 | | |
萨姆·斯里瓦斯塔瓦
|
| | | | 575,000 | | |
名称
|
| |
2020基数
工资($) |
| |
目标奖金
(%) |
| |
目标奖金
金额($) |
| |
实际奖金
已支付($)(1) |
| ||||||||||||
G.Mike Mikan
|
| | | | 600,000 | | | | | | 75 | | | | | | 450,000 | | | | | | 585,000 | | |
凯西·史密斯
|
| | | | 450,000 | | | | | | 75 | | | | | | 337,500 | | | | | | 454,375 | | |
罗伯特·希伊
|
| | | | 600,000 | | | | | | 75 | | | | | | 450,000 | | | | | | 540,000 | | |
基思·尼尔森
|
| | | | 400,000 | | | | | | 60 | | | | | | 240,000 | | | | | | 193,600 | | |
西蒙·辛德尔曼
|
| | | | 400,000 | | | | | | 60 | | | | | | 240,000 | | | | | | 327,000 | | |
萨姆·斯里瓦斯塔瓦
|
| | | | 400,000 | | | | | | 60 | | | | | | 240,000 | | | | | | 327,000 | | |
名称
|
| |
2021目标
奖金(%) |
| |||
G.Mike Mikan
|
| | | | 130 | | |
凯西·史密斯
|
| | | | 90 | | |
基思·尼尔森
|
| | | | 70 | | |
西蒙·辛德尔曼
|
| | | | 75 | | |
萨姆·斯里瓦斯塔瓦
|
| | | | 75 | | |
名称
|
| |
授予日期
|
| |
数量
授予期权 |
| |
行使价
每股($) |
| |||||||||
G.Mike Mikan
|
| | | | 2/19/2020 | | | | | | 5,235,000 | | | | | | 1.77 | | |
| | | | | 11/19/2020 | | | | | | 1,650,000 | | | | | | 2.30 | | |
凯西·史密斯
|
| | | | 2/19/2020 | | | | | | 600,000 | | | | | | 1.77 | | |
| | | | | 11/19/2020 | | | | | | 450,000 | | | | | | 2.30 | | |
罗伯特·希伊
|
| | | | 2/19/2020 | | | | | | 4,008,000 | | | | | | 1.77 | | |
| | | | | 11/19/2020 | | | | | | 750,000 | | | | | | 2.30 | | |
基思·尼尔森
|
| | | | 5/28/2020 | | | | | | 1,800,000 | | | | | | 1.77 | | |
| | | | | 11/19/2020 | | | | | | 225,000 | | | | | | 2.30 | | |
西蒙·辛德尔曼
|
| | | | 2/19/2020 | | | | | | 75,534 | | | | | | 1.77 | | |
| | | | | 5/28/2020 | | | | | | 450,000 | | | | | | 1.77 | | |
| | | | | 11/19/2020 | | | | | | 300,000 | | | | | | 2.30 | | |
萨姆·斯里瓦斯塔瓦
|
| | | | 2/19/2020 | | | | | | 68,667 | | | | | | 1.77 | | |
| | | | | 5/28/2020 | | | | | | 450,000 | | | | | | 1.77 | | |
| | | | | 11/19/2020 | | | | | | 300,000 | | | | | | 2.30 | | |
名称
|
| |
数量
授予期权 |
| |||
G.Mike Mikan
|
| | | | 7,812,288 | | |
凯西·史密斯
|
| | | | 1,200,000 | | |
罗伯特·希伊
|
| | | | — | | |
基思·尼尔森
|
| | | | 675,000 | | |
西蒙·辛德尔曼
|
| | | | 1,050,000 | | |
萨姆·斯里瓦斯塔瓦
|
| | | | 1,200,000 | | |
归属部分(25%的PSU)
|
| |
欣赏
必填 来自 公共 提供服务 价格 |
| |
每件价格
共享目标 |
| ||||||
第一批归属
|
| | | | 50% | | | | | $ | 27.00 | | |
第二批归属
|
| | | | 100% | | | | | $ | 36.00 | | |
第三批归属
|
| | | | 150% | | | | | $ | 45.00 | | |
第四批归属
|
| | | | 200% | | | | | $ | 54.00 | | |
名称
|
| |
标题
|
| |
合计
PSU奖励 |
|
G.Mike Mikan | | | 首席执行官 | | | 7,350,000 | |
凯西·史密斯 | | | 首席财务和行政官 | | | 1,050,000 | |
基思·尼尔森 | | | 总法律顾问 | | | 1,050,000 | |
西蒙·辛德尔曼 | | |
光明医疗首席执行官
|
| | 1,050,000 | |
萨姆·斯里瓦斯塔瓦 | | | NeueHealth首席执行官 | | | 1,050,000 | |
其他行政领导团队成员 | | | 不适用 | | | 3,150,000 | |
姓名和主要职务
|
| |
年
|
| |
工资
($)(1) |
| |
奖金
($)(2) |
| |
期权奖励
($)(3) |
| |
所有其他
薪酬 ($)(4) |
| |
合计
($) |
| ||||||||||||||||||
G.Mike Mikan
首席执行官5/1/20 - 12/ 31/20 |
| | | | 2020 | | | | | | 600,000 | | | | | | 585,000 | | | | | | 4,141,805 | | | | | | 162,018 | | | | | | 5,488,823 | | |
凯西·史密斯
首席财务官 |
| | | | 2020 | | | | | | 445,096 | | | | | | 454,375 | | | | | | 672,660 | | | | | | 10,125 | | | | | | 1,582,256 | | |
罗伯特·希伊
首席执行官1/1/20 - 4/30/20 |
| | | | 2020 | | | | | | 600,000 | | | | | | 540,000 | | | | | | 2,783,174 | | | | | | 17,925 | | | | | | 3,941,099 | | |
基思·尼尔森
总法律顾问 |
| | | | 2020 | | | | | | 265,384 | | | | | | 193,600 | | | | | | 1,195,830 | | | | | | 5,000 | | | | | | 1,659,814 | | |
西蒙·辛德尔曼
首席执行官 警官 - Bright Healthcare |
| | | | 2020 | | | | | | 400,000 | | | | | | 327,000 | | | | | | 525,350 | | | | | | 13,031 | | | | | | 1,265,381 | | |
萨姆·斯里瓦斯塔瓦
首席执行官 - NeueHealth |
| | | | 2020 | | | | | | 400,000 | | | | | | 327,000 | | | | | | 521,617 | | | | | | 12,946 | | | | | | 1,261,563 | | |
名称
|
| |
奖项
类型 |
| |
授予
日期(1) |
| |
全部
其他 库存 奖项: 号码 共 个 个 个共享 库存 个 或单位 (#) |
| |
所有其他
选项 奖项: 数量 证券 底层 选项(#) |
| |
练习
或基础 价格为 选项 奖项 ($/ 共享) |
| |
授予
日期 公平 值 库存 和 选项 奖项 ($)(2) |
| |||||||||||||||
G.Mike Mikan
|
| | | | 选项 | | | | | | 2/19/2020 | | | | | | | | | 5,235,000 | | | | | | 1.77 | | | | | | 2,894,955 | | |
| | | | | 选项 | | | | | | 11/19/2020 | | | | | | | | | 1,650,000 | | | | | | 2.30 | | | | | | 1,246,850 | | |
凯西·史密斯
|
| | | | 选项 | | | | | | 2/19/2020 | | | | | | | | | 600,000 | | | | | | 1.77 | | | | | | 331,800 | | |
| | | | | 选项 | | | | | | 11/19/2020 | | | | | | | | | 450,000 | | | | | | 2.30 | | | | | | 340,860 | | |
罗伯特·希伊
|
| | | | 选项 | | | | | | 2/19/2020 | | | | | | | | | 4,008,000 | | | | | | 1.77 | | | | | | 2,216,424 | | |
| | | | | 选项 | | | | | | 11/19/2020 | | | | | | | | | 750,000 | | | | | | 2.30 | | | | | | 566,750 | | |
基思·尼尔森
|
| | | | 选项 | | | | | | 5/28/2020 | | | | | | | | | 1,800,000 | | | | | | 1.77 | | | | | | 1,025,400 | | |
| | | | | 选项 | | | | | | 11/19/2020 | | | | | | | | | 225,000 | | | | | | 2.30 | | | | | | 170,430 | | |
西蒙·辛德尔曼
|
| | | | 选项 | | | | | | 2/19/2020 | | | | | | | | | 75,534 | | | | | | 1.77 | | | | | | 41,070 | | |
| | | | | 选项 | | | | | | 5/28/2020 | | | | | | | | | 450,000 | | | | | | 1.77 | | | | | | 257,040 | | |
| | | | | 选项 | | | | | | 11/19/2020 | | | | | | | | | 300,000 | | | | | | 2.30 | | | | | | 227,240 | | |
萨姆·斯里瓦斯塔瓦
|
| | | | 选项 | | | | | | 2/19/2020 | | | | | | | | | 68,667 | | | | | | 1.77 | | | | | | 37,337 | | |
| | | | | 选项 | | | | | | 5/28/2020 | | | | | | | | | 450,000 | | | | | | 1.77 | | | | | | 257,040 | | |
| | | | | 选项 | | | | | | 11/19/2020 | | | | | | | | | 300,000 | | | | | | 2.30 | | | | | | 227,240 | | |
| | | | | | | | | | | | | | |
期权奖励
|
| ||||||||||||||||||||||||
名称
|
| |
授予
日期 |
| |
归属
开工 日期(1) |
| |
数量
证券 底层 未锻炼 选项 可锻炼 (#)(2) |
| |
数量
证券 底层 未锻炼 选项 不可行使 (#)(3) |
| |
股权
奖励 计划 奖项: 数量 证券 底层 未锻炼 不劳而获 选项 (#) |
| |
选项
练习 价格 ($) |
| |
选项
过期 日期(4) |
| ||||||||||||||||||
G.Mike Mikan
|
| | | | 1/23/2019 | | | | | | 1/15/2019 | | | | | | 5,412,186 | | | | | | 5,882,814 | | | | | | | | | 1.04 | | | | | | 1/22/2029 | | |
| | | | | 2/19/2020 | | | | | | 2/19/2020 | | | | | | | | | | | | 5,235,000 | | | | | | | | | 1.77 | | | | | | 2/18/2030 | | |
| | | | | 11/19/2020 | | | | | | 11/19/2020 | | | | | | | | | | | | 1,650,000 | | | | | | | | | 2.30 | | | | | | 11/18/2030 | | |
凯西·史密斯
|
| | | | 11/4/2019 | | | | | | 1/6/2020 | | | | | | | | | | | | 2,550,000 | | | | | | | | | 1.77 | | | | | | 11/3/2029 | | |
| | | | | 2/19/2020 | | | | | | 2/19/2020 | | | | | | | | | | | | 600,000 | | | | | | | | | 1.77 | | | | | | 2/18/2030 | | |
| | | | | 11/19/2020 | | | | | | 12/18/2020 | | | | | | | | | | | | 450,000 | | | | | | | | | 2.30 | | | | | | 11/18/2030 | | |
罗伯特·希伊
|
| | | | 2/19/2020 | | | | | | 2/19/2020 | | | | | | | | | | | | 4,008,000 | | | | | | | | | 1.77 | | | | | | 2/18/2030 | | |
| | | | | 11/19/2020 | | | | | | 11/19/2020 | | | | | | | | | | | | 750,000 | | | | | | | | | 2.30 | | | | | | 11/18/2030 | | |
基思·尼尔森
|
| | | | 5/28/2020 | | | | | | 5/4/2020 | | | | | | | | | | | | 1,800,000 | | | | | | | | | 1.77 | | | | | | 5/27/2030 | | |
| | | | | 11/19/2020 | | | | | | 12/18/2020 | | | | | | | | | | | | 225,000 | | | | | | | | | 2.30 | | | | | | 11/18/2030 | | |
西蒙·辛德尔曼
|
| | | | 11/4/2019 | | | | | | 9/16/2019 | | | | | | 459,237 | | | | | | 1,134,375 | | | | | | | | | 1.77 | | | | | | 11/3/2029 | | |
| | | 2/19/2020 | | | | | | 9/16/2019 | | | | | | 23,604 | | | | | | 51,930 | | | | | | | | | 1.77 | | | | | | 2/18/2030 | | | ||
| | | 5/28/2020 | | | | | | 5/28/2020 | | | | | | | | | | | | 450,000 | | | | | | | | | 1.77 | | | | | | 5/27/2030 | | | ||
| | | 11/19/2020 | | | | | | 12/18/2020 | | | | | | | | | | | | 300,000 | | | | | | | | | 2.30 | | | | | | 11/18/2030 | | | ||
萨姆·斯里瓦斯塔瓦
|
| | | | 11/4/2019 | | | | | | 9/16/2019 | | | | | | 468,750 | | | | | | 1,031,250 | | | | | | | | | 1.77 | | | | | | 11/3/2029 | | |
| | | | | 2/19/2020 | | | | | | 9/16/2019 | | | | | | 21,456 | | | | | | 47,211 | | | | | | | | | 1.77 | | | | | | 2/18/2030 | | |
| | | | | 5/28/2020 | | | | | | 5/28/2020 | | | | | | | | | | | | 450,000 | | | | | | | | | 1.77 | | | | | | 5/27/2030 | | |
| | | | | 11/19/2020 | | | | | | 12/18/2020 | | | | | | | | | | | | 300,000 | | | | | | | | | 2.30 | | | | | | 11/18/2030 | | |
| | |
期权奖励
|
| |||||||||
名称
|
| |
股份数量
通过练习获得的 (#) |
| |
在
上实现的价值
练习 ($)(1) |
| ||||||
西蒙·辛德尔曼
|
| | | | 56,388 | | | | | | 29,698 | | |
福利
|
| |
终止
没有 原因 不在 中 连接 更改后的 控件中的 ($) |
| |
死亡($)
|
| |
终止
没有 原因 连接 更改后的 中的 控件 ($) |
| |||||||||
现金分期付款(工资和奖金)
|
| | | | 2,100,000(1) | | | | | | | | | | | | 2,100,000(1) | | |
选项值
|
| | | | 4,821,595(2) | | | | | | 8,331,380(3) | | | | | | 10,169,446(4) | | |
合计
|
| | | | 6,921,595 | | | | | | 8,331,380 | | | | | | 12,269,446 | | |
福利
|
| |
终止
没有 原因 ($) |
| |||
现金分期付款(工资)
|
| | | | 300,000(1) | | |
合计 | | | | | 300,000 | | |
福利
|
| |
终止
无缘无故 ($) |
| |||
现金分期付款(工资)
|
| | | | 200,000(1) | | |
合计 | | | | | 200,000 | | |
福利
|
| |
终止
无缘无故 ($) |
| |||
现金分期付款(工资和奖金)
|
| | | | 421,875(1) | | |
合计 | | | | | 421,875 | | |
福利
|
| |
终止
无缘无故 ($) |
| |||
现金分期付款(工资)
|
| | | | 400,000(1) | | |
合计 | | | | | 400,000 | | |
员工级别
|
| |
员工级别
|
| |
周的遣散费
|
|
执行领导团队 | | |
23 – 24
|
| | 18个月 | |
高级副总裁 | | |
20 – 22
|
| | 12个月 | |
副总裁 | | |
19
|
| | 6个月 | |
董事、高级总监 | | |
17 – 18
|
| | 四周外加每满一年服务一周,最短12周,最长26周 | |
所有其他员工 | | |
10 – 16
|
| | 四周外加每满一年服务一周,最长为26周 | |
员工级别
|
| |
员工级别
|
| |
周的遣散费
|
|
执行领导团队(ELT) | | |
23 – 24
|
| | 78周基本工资外加相当于学员目标奖金1.5倍的金额,在分期付款期间支付 | |
高级副总裁(高级副总裁) | | |
20 – 22
|
| | 52周基本工资外加相当于学员目标奖金的金额,在离职期内支付 | |
副总裁 | | |
19
|
| | 26周基本工资外加相当于学员目标奖金金额0.5倍的金额,在分期付款期间支付 | |
董事、高级总监 | | |
17 – 18
|
| | 四周外加每满一年服务一周,最短12周,最长26周 | |
所有其他员工 | | |
10 – 16
|
| | 四周外加每满一年服务一周,最长为26周 | |
员工级别
|
| |
员工级别
|
| |
福利补贴期限
|
|
执行领导团队 | | |
23 – 24
|
| | 18个月 | |
高级副总裁 | | |
20 – 22
|
| | 12个月 | |
副总裁 | | |
19
|
| | 6个月 | |
董事、高级总监 | | |
17 – 18
|
| | 服务期内每个日历月,最短3个月,最长6个月 | |
所有其他员工 | | |
10 – 16
|
| | 服务期内每个日历月,最长6个月。 | |
员工级别
|
| |
非竞争,
非邀请函和 非贬损期 |
|
23 – 24 | | | 18个月 | |
19 – 22 | | | 12个月 | |
10 – 18 | | | 服务期间(如上定义) | |
名称
|
| |
赚取的费用或
现金支付 ($)(1) |
| |
选项
奖项 ($)(2)(3)(4) |
| |
总计($)
|
| |||||||||
小凯德里克·D·阿德金斯(Kedrick D.Adkins Jr.)
|
| | | | 17,250 | | | | | | 298,620 | | | | | | 315,870 | | |
娜奥米·艾伦
|
| | | | 17,250 | | | | | | 298,620 | | | | | | 315,870 | | |
杰弗里·R·伊梅尔特
|
| | | | — | | | | | | 308,448 | | | | | | 308,448 | | |
曼努埃尔·卡德雷
|
| | | | 2,300 | | | | | | 408,060 | | | | | | 410,360 | | |
名称
|
| |
股份
系列C 首选 库存(1) |
| |
股份
系列D 首选 库存(2) |
| |
股份
系列E 首选 库存(3) |
| |
聚合
进货价格 |
| ||||||||||||
| | | | | | | | | | | | | | | | | | | | |
(千)
|
| |||
新增企业合伙人及关联基金(4)
|
| | | | 8,471,262 | | | | | | 28,572,947 | | | | | | 6,970,570 | | | | | | $ 636,623 | | |
Bessemer风险合作伙伴及其附属基金(5)
|
| | | | 3,258,177 | | | | | | 3,993,424 | | | | | | 2,602,800 | | | | | | 138,071 | | |
绿泉及其附属基金(6)
|
| | | | 2,606,540 | | | | | | 1,663,924 | | | | | | 1,714,200 | | | | | | 80,000 | | |
杰弗里·福利克(7)
|
| | | | 32,079 | | | | | | 13,311 | | | | | | — | | | | | | 446 | | |
杰弗里·R·伊梅尔特(8)
|
| | | | — | | | | | | 13,311 | | | | | | 14,693 | | | | | | 500 | | |
| | | | | | | | | | | | | | |
股票受益
上市后拥有 |
| |||||||||||||||||||||
| | |
个共享
受益 以前拥有的 至 提供服务 |
| |
个共享
受益 之前拥有 产品 |
| |
如果承销商‘
到 的选项 额外购买 共享为 未行使 |
| |
如果承销商‘
到 的选项 额外购买 共享为 全面锻炼 |
| ||||||||||||||||||||||||
受益人姓名
|
| |
个共享
|
| |
百分比
|
| |
个共享
|
| |
百分比
|
| |
个共享
|
| |
百分比
|
| ||||||||||||||||||
5%股东: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
新企业合伙人及附属基金(1)
|
| | | | 216,267,684 | | | | | | 37.7% | | | | | | 216,267,684 | | | | | | 34.6% | | | | | | 216,267,684 | | | | | | 34.3% | | |
贝塞默风险投资伙伴及附属基金(2)
|
| | | | 79,937,724 | | | | | | 13.9% | | | | | | 79,937,724 | | | | | | 12.8% | | | | | | 79,937,724 | | | | | | 12.7% | | |
绿泉及其附属基金(3)
|
| | | | 43,040,376 | | | | | | 7.5% | | | | | | 43,040,376 | | | | | | 6.9% | | | | | | 43,040,376 | | | | | | 6.8% | | |
董事和指定高管(4):
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
G.Mike Mikan(5)
|
| | | | 10,263,435 | | | | | | 1.8% | | | | | | 10,263,435 | | | | | | 1.6% | | | | | | 10,263,435 | | | | | | 1.6% | | |
凯瑟琳·R·史密斯(6)
|
| | | | 1,168,749 | | | | | | * | | | | | | 1,168,749 | | | | | | * | | | | | | 1,168,749 | | | | | | * | | |
萨姆·斯里瓦斯塔瓦(7)
|
| | | | 840,843 | | | | | | * | | | | | | 840,843 | | | | | | * | | | | | | 840,843 | | | | | | * | | |
基思·尼尔森(8)
|
| | | | 525,000 | | | | | | * | | | | | | 525,000 | | | | | | * | | | | | | 525,000 | | | | | | * | | |
西蒙·辛德尔曼(9)
|
| | | | 912,741 | | | | | | * | | | | | | 912,741 | | | | | | * | | | | | | 912,741 | | | | | | * | | |
Robert J.Sheehy(10)
|
| | | | 21,474,735 | | | | | | 3.7% | | | | | | 21,474,735 | | | | | | 3.4% | | | | | | 21,474,735 | | | | | | 3.4% | | |
小Kedrick D.Adkins Jr.(11)
|
| | | | 191,250 | | | | | | * | | | | | | 191,250 | | | | | | * | | | | | | 191,250 | | | | | | * | | |
娜奥米·艾伦(12岁)
|
| | | | 191,250 | | | | | | * | | | | | | 191,250 | | | | | | * | | | | | | 191,250 | | | | | | * | | |
杰弗里·福利克(13)
|
| | | | 1,599,810 | | | | | | * | | | | | | 1,599,810 | | | | | | * | | | | | | 1,599,810 | | | | | | * | | |
琳达·古登
|
| | | | — | | | | | | | | | | | | — | | | | | | | | | | | | — | | | | | | | | |
杰弗里·R·伊梅尔特(14)
|
| | | | 230,262 | | | | | | * | | | | | | 230,262 | | | | | | * | | | | | | 230,262 | | | | | | * | | |
曼努埃尔·卡德雷
|
| | | | — | | | | | | | | | | | | — | | | | | | | | | | | | — | | | | | | | | |
史蒂夫·克劳斯(2)
|
| | | | — | | | | | | | | | | | | — | | | | | | | | | | | | — | | | | | | | | |
穆罕默德·马赫祖米(1)(15)
|
| | | | 216,209,181 | | | | | | 37.7% | | | | | | 216,209,181 | | | | | | 34.6% | | | | | | 216,209,181 | | | | | | 34.3% | | |
阿代尔·纽荷尔(16)
|
| | | | 224,628 | | | | | | * | | | | | | 224,628 | | | | | | * | | | | | | 224,628 | | | | | | * | | |
所有董事和高管
作为一个团队(16人) |
| | | | 236,748,123 | | | | | | 40.4% | | | | | | 236,748,123 | | | | | | 37.1% | | | | | | 236,748,123 | | | | | | 36.8% | | |
公开市场销售的最早日期
|
| |
普通股股数
|
|
在2021年9月7日或之后,只要我们普通股在纽约证券交易所的收盘价比本招股说明书封面上所述的每股首次公开募股价格高出33%以上,该价格在标题为“承销(利益冲突)”一节中所述的期间内。 | | | 假设转换我们的优先股,基于截至2021年3月31日的已发行普通股数量,最高可达5640万股。 | |
在本招股说明书发布之日后180个交易日内,如果此类发布发生在定期安排的交易禁售期开始后的九个交易日内,则上述到期日将改为紧接该交易禁售期开始前的第十个交易日。 | | | 我们的股东持有的所有以前没有资格出售的剩余股份,均受下文所述规则第144条适用于“关联公司”的数量限制。 | |
名称
|
| |
数量
个共享 |
| |||
摩根大通证券有限责任公司
|
| | | | 11,297,000 | | |
高盛有限责任公司
|
| | | | 11,297,000 | | |
摩根士丹利有限责任公司
|
| | | | 9,756,500 | | |
巴克莱资本公司
|
| | | | 9,756,500 | | |
美国银行证券公司
|
| | | | 4,621,500 | | |
花旗全球市场公司
|
| | | | 2,054,000 | | |
派珀·桑德勒公司
|
| | | | 1,027,000 | | |
野村证券国际公司
|
| | | | 770,250 | | |
RBC Capital Markets有限责任公司
|
| | | | 770,250 | | |
合计
|
| | | | 51,350,000 | | |
| | |
没有
到 的选项 购买 其他 个共享 练习 |
| |
已满
到 的选项 购买 其他 个共享 练习 |
| ||||||
每股
|
| | | $ | 0.72 | | | | | $ | 0.72 | | |
合计
|
| | | $ | 36,972,000 | | | | | $ | 41,408,640 | | |
| 光明健康集团未经审计的简明合并财务报表 | | | | | | | |
|
截至2021年3月31日(重报)和12月31日的简明合并资产负债表
2020 |
| | | | F-2 | | |
|
截至2021年3月31日(重报)和2020年3月31日止三个月的简明合并损益表
|
| | | | F-3 | | |
|
截至2021年3月31日(重报)和2020年3月31日止三个月简明综合全面收益(亏损)报表
|
| | | | F-4 | | |
|
截至2021年3月31日(重述)和2020年3月31日止三个月的可赎回优先股变动及股东亏损简明综合报表
|
| | | | F-5 | | |
|
截至2021年3月31日的三个月现金流量表简明合并报表
(重述)和2020年3月31日 |
| | | | F-6 | | |
|
截至2021年3月31日(重述)和2020年3月31日止三个月简明合并财务报表附注
|
| | | | F-7 | | |
| 光明健康集团经审计的合并财务报表 | | | | | | | |
|
独立注册会计师事务所报告
|
| | | | F-25 | | |
|
独立注册会计师事务所报告
|
| | | | F-29 | | |
|
截至2020年12月31日和2019年12月31日的合并资产负债表
|
| | | | F-30 | | |
|
截至2018年12月31日、2020年12月31日、2019年12月31日和2018年12月31日的合并损益表
|
| | | | F-31 | | |
|
截至2018年12月31日、2020年12月31日、2019年12月31日和2018年12月31日的综合全面收益(亏损)报表
|
| | | | F-32 | | |
|
截至2020年12月31日、2019年12月31日和2018年12月31日的年度可赎回优先股变动和股东赤字合并报表
|
| | | | F-33 | | |
|
截至2018年12月31日、2020年12月31日、2019年12月31日和2018年12月31日的合并现金流量表
|
| | | | F-34 | | |
|
截至2020年12月31日止年度经审计合并财务报表附注
2019年和2018年 |
| | | | F-35 | | |
| Universal Care,Inc.未经审计的简明财务报表 | | | | | | | |
|
截至2020年4月30日的浓缩资产负债表
|
| | | | F-65 | | |
|
截至2020年4月30日的十个月简明运营报表
|
| | | | F-66 | | |
|
截至2020年4月30日的10个月股东赤字简表
|
| | | | F-67 | | |
|
截至2020年4月30日的十个月现金流量表简表
|
| | | | F-68 | | |
|
截至2010年4月30日的十个月简明未经审计财务报表附注
2020 |
| | | | F-69 | | |
| Universal Care,Inc.经审计的财务报表 | | | | | | | |
|
独立审计师报告
|
| | | | F-81 | | |
|
截至2019年6月30日的资产负债表
|
| | | | F-82 | | |
|
截至2019年6月30日的年度营业报表
|
| | | | F-83 | | |
|
截至2019年6月30日的年度股东亏损表
|
| | | | F-84 | | |
|
截至2019年6月30日的年度现金流量表
|
| | | | F-85 | | |
|
截至2019年6月30日的年度经审计财务报表附注
|
| | | | F-86 | | |
| | |
3月31日
2021 (重申,见注14) |
| |
12月31日
2020 |
| ||||||
资产 | | | | | | | | | | | | | |
流动资产: | | | | | | | | | | | | | |
现金和现金等价物
|
| | | $ | 975,933 | | | | | $ | 488,371 | | |
短期投资
|
| | | | 274,578 | | | | | | 499,928 | | |
应收账款,扣除备用金分别为3750美元和2602美元
|
| | | | 85,486 | | | | | | 60,522 | | |
预付和其他流动资产
|
| | | | 164,321 | | | | | | 130,986 | | |
流动资产总额
|
| | | | 1,500,318 | | | | | | 1,179,807 | | |
其他资产: | | | | | | | | | | | | | |
长期投资
|
| | | | 448,903 | | | | | | 175,176 | | |
财产、设备和大写软件,净额
|
| | | | 15,784 | | | | | | 12,264 | | |
商誉
|
| | | | 328,983 | | | | | | 263,035 | | |
无形资产净值
|
| | | | 166,726 | | | | | | 152,211 | | |
其他非流动资产
|
| | | | 27,404 | | | | | | 28,309 | | |
其他资产合计
|
| | | | 987,800 | | | | | | 630,995 | | |
总资产
|
| | | $ | 2,488,118 | | | | | $ | 1,810,802 | | |
负债、可赎回非控股权益、可赎回优先股和股东亏损
|
| | | | | | | | | | | | |
流动负债: | | | | | | | | | | | | | |
应付医疗费用
|
| | | $ | 488,859 | | | | | $ | 249,777 | | |
应付帐款
|
| | | | 85,146 | | | | | | 57,252 | | |
未赚取收入
|
| | | | 39,311 | | | | | | 34,628 | | |
应付风险调整
|
| | | | 326,310 | | | | | | 187,777 | | |
短期借款
|
| | | | 200,000 | | | | | | — | | |
其他流动负债
|
| | | | 56,707 | | | | | | 35,847 | | |
流动负债总额
|
| | | | 1,196,333 | | | | | | 565,281 | | |
其他负债
|
| | | | 35,223 | | | | | | 28,578 | | |
总负债
|
| | | | 1,231,556 | | | | | | 593,859 | | |
承付款和或有事项(附注10) | | | | | | | | | | | | | |
可赎回的非控股权益
|
| | | | 40,217 | | | | | | 39,600 | | |
可赎回优先股,面值0.0001美元;168,065,332股和166,307,087股
分别于2021年和2020年授权发行了165,664,947股和164,244,893股 ,分别在2021年和2020年表现突出 |
| | | | 1,736,152 | | | | | | 1,681,015 | | |
股东亏损: | | | | | | | | | | | | | |
普通股,面值0.0001美元;
授权的674,593,725股和658,993,725股
2021年和2020年分别为142,323,510股和137,662,698股, 分别在2021年和2020年完成 |
| | | | 14 | | | | | | 14 | | |
新增实收资本
|
| | | | 19,946 | | | | | | 9,877 | | |
累计亏损
|
| | | | (541,151) | | | | | | (515,989) | | |
累计其他综合收益
|
| | | | 1,384 | | | | | | 2,426 | | |
股东亏损总额
|
| | | | (519,807) | | | | | | (503,672) | | |
总负债、可赎回非控股权益、可赎回优先股和股东亏损
|
| | | $ | 2,488,118 | | | | | $ | 1,810,802 | | |
| | |
截至3月31日的三个月
|
| |||||||||
| | |
2021
(重申,见注14) |
| |
2020
|
| ||||||
收入: | | | | | | | | | | | | | |
保费收入
|
| | | | $ 860,631 | | | | | | $ 190,737 | | |
服务收入
|
| | | | 8,438 | | | | | | 4,820 | | |
投资收益
|
| | | | 5,489 | | | | | | 3,009 | | |
总收入
|
| | | | 874,558 | | | | | | 198,566 | | |
运营成本: | | | | | | | | | | | | | |
医疗费用
|
| | | | 684,570 | | | | | | 130,615 | | |
运营成本
|
| | | | 208,240 | | | | | | 74,444 | | |
折旧摊销
|
| | | | 4,581 | | | | | | 787 | | |
总运营成本
|
| | | | 897,391 | | | | | | 205,846 | | |
营业亏损
|
| | | | (22,833) | | | | | | (7,280) | | |
利息支出
|
| | | | 546 | | | | | | — | | |
所得税前亏损
|
| | | | (23,379) | | | | | | (7,280) | | |
所得税(福利)费用
|
| | | | 1,166 | | | | | | — | | |
净亏损
|
| | | | (24,545) | | | | | | (7,280) | | |
可归因于非控股权益的净收益
|
| | | | (617) | | | | | | — | | |
光明健康集团普通股股东应占净亏损
|
| | | | $ (25,162) | | | | | | $ (7,280) | | |
光明健康集团(Bright Health Group,Inc.)普通股股东应占每股基本和摊薄亏损
|
| | | | $ (0.18) | | | | | | $ (0.05) | | |
已发行基本和稀释加权平均普通股
|
| | | | 140,175 | | | | | | 137,125 | | |
| | |
截至3月31日的三个月
|
| |||||||||
| | |
2021
(重申,见注14) |
| |
2020
|
| ||||||
净亏损
|
| | | | $ (24,545) | | | | | | $ (7,280) | | |
其他综合收益(亏损): | | | | | | | | | | | | | |
本年度产生的未实现投资持有收益(亏损),税后净额分别为0美元和0美元
|
| | | | (980) | | | | | | 890 | | |
减去:对投资收益(亏损)的重新分类调整,扣除
分别为0美元和0美元的税 |
| | | | 62 | | | | | | (61) | | |
其他综合收益(亏损)
|
| | | | (1,042) | | | | | | 951 | | |
全面亏损
|
| | | | (25,587) | | | | | | (6,329) | | |
非控股权益综合收益
|
| | | | (617) | | | | | | — | | |
光明健康集团普通股股东应占综合亏损
|
| | | | $ (26,204) | | | | | | $ (6,329) | | |
| | |
可赎回优先股
|
| | |
普通股
|
| |
其他
实收 大写 |
| |
保留
收入 (赤字) |
| |
累计
其他 综合 收入(亏损) |
| |
合计
|
| ||||||||||||||||||||||||||||||
| | |
个共享
|
| |
金额
|
| | |
个共享
|
| |
金额
|
| ||||||||||||||||||||||||||||||||||||
2021年1月1日的余额
|
| | | | 164,245 | | | | | | 1,681,015 | | | | | | | 137,663 | | | | | | $ 14 | | | | | | $ 9,877 | | | | | | $ (515,989) | | | | | | $ 2,426 | | | | | | $ (503,672) | | |
净亏损(1)
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | (25,162) | | | | | | — | | | | | | (25,162) | | |
优先股发行(1)
|
| | | | 1,420 | | | | | | 55,137 | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
普通股发行
|
| | | | — | | | | | | — | | | | | | | 4,661 | | | | | | — | | | | | | 4,893 | | | | | | — | | | | | | — | | | | | | 4,893 | | |
基于股份的薪酬(1)
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | 5,176 | | | | | | — | | | | | | — | | | | | | 5,176 | | |
其他综合亏损
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (1,042) | | | | | | (1,042) | | |
2021年3月31日的余额(重新声明)
|
| | | | 165,665 | | | | | | $ 1,736,152 | | | | | | | 142,324 | | | | | | $ 14 | | | | | | $ 19,946 | | | | | | $ (541,151) | | | | | | $ 1,384 | | | | | | $ (519,807) | | |
2020年1月1日的余额
|
| | | | 119,222 | | | | | | 871,990 | | | | | | | 135,509 | | | | | | 14 | | | | | | 3,184 | | | | | | (267,547) | | | | | | 982 | | | | | | (263,367) | | |
净亏损
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | (7,280) | | | | | | — | | | | | | (7,280) | | |
普通股发行
|
| | | | — | | | | | | — | | | | | | | 183 | | | | | | — | | | | | | 13 | | | | | | — | | | | | | — | | | | | | 13 | | |
基于股份的薪酬
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | 943 | | | | | | — | | | | | | — | | | | | | 943 | | |
其他综合收益
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 951 | | | | | | 951 | | |
2020年3月31日的余额
|
| | | | 119,222 | | | | | | $ 871,990 | | | | | | | 135,692 | | | | | | $ 14 | | | | | | $ 4,140 | | | | | | $ (274,827) | | | | | | $ 1,933 | | | | | | $ (268,740) | | |
| | |
截至3月31日的三个月
|
| |||||||||
| | |
2021
(如上所述, 参见备注14) |
| |
2020
|
| ||||||
经营活动现金流: | | | | | | | | | | | | | |
净亏损
|
| | | | $ (25,162) | | | | | | $ (7,280) | | |
将净亏损与经营活动提供的现金净额进行调整:
|
| | | | | | | | | | | | |
折旧摊销
|
| | | | 4,581 | | | | | | 787 | | |
基于股份的薪酬
|
| | | | 5,176 | | | | | | 943 | | |
递延所得税
|
| | | | 1,166 | | | | | | — | | |
其他,净额
|
| | | | 2,694 | | | | | | 146 | | |
扣除收购资产和负债后的资产和负债变动:
|
| | | | | | | | | | | | |
应收账款
|
| | | | (23,188) | | | | | | (6,805) | | |
其他资产
|
| | | | (15,707) | | | | | | (2,552) | | |
应付医疗费用
|
| | | | 225,814 | | | | | | 53,822 | | |
应付风险调整
|
| | | | 137,215 | | | | | | 48,597 | | |
应付帐款和其他负债
|
| | | | 30,096 | | | | | | (6,246) | | |
未赚取收入
|
| | | | 918 | | | | | | 874 | | |
经营活动提供的净现金
|
| | | | 343,603 | | | | | | 82,286 | | |
投资活动现金流: | | | | | | | | | | | | | |
购买投资
|
| | | | (298,957) | | | | | | (387,665) | | |
投资的销售、支付和到期日收益
|
| | | | 265,521 | | | | | | 49,314 | | |
购置房产和设备
|
| | | | (4,215) | | | | | | (8) | | |
业务收购,扣除收购现金后的净额
|
| | | | (18,624) | | | | | | — | | |
投资活动使用的净现金
|
| | | | (56,275) | | | | | | (338,359) | | |
融资活动现金流: | | | | | | | | | | | | | |
短期借款收益
|
| | | | 200,000 | | | | | | — | | |
普通股发行收益
|
| | | | 4,893 | | | | | | 13 | | |
发债成本支付
|
| | | | (3,391) | | | | | | — | | |
IPO发行费用支付
|
| | | | (1,268) | | | | | | — | | |
融资活动提供的净现金
|
| | | | 200,234 | | | | | | 13 | | |
现金及现金等价物净增(减)
|
| | | | 487,562 | | | | | | (256,060) | | |
年初 - 现金和现金等价物
|
| | | | 488,371 | | | | | | 522,910 | | |
现金和现金等价物 - 期末
|
| | | | $ 975,933 | | | | | | $ 266,850 | | |
现金流量信息补充披露: | | | | | | | | | | | | | |
OCI中可供出售证券的未实现损益变化
|
| | | | $ (1,042) | | | | | | $ 951 | | |
付息现金
|
| | | | 244 | | | | | | — | | |
非现金活动补充日程表: | | | | | | | | | | | | | |
为收购而发行的可赎回优先股
|
| | | | $ 32,982 | | | | | | $ — | | |
| | |
2021
|
| |
2020
|
| ||||||
薪酬和附带福利
|
| | | | $ 57,026 | | | | | | $ 25,554 | | |
专业费
|
| | | | 39,463 | | | | | | 17,212 | | |
营销和销售费用
|
| | | | 50,205 | | | | | | 8,640 | | |
其他运营费用
|
| | | | 61,546 | | | | | | 23,038 | | |
总运营成本
|
| | | | $ 208,240 | | | | | | $ 74,444 | | |
|
应收账款
|
| | | $ | 5,674 | | |
|
预付和其他流动资产
|
| | | | 18,692 | | |
|
物业和设备
|
| | | | 353 | | |
|
无形资产
|
| | | | 110,000 | | |
|
总资产
|
| | | | 134,719 | | |
|
应付医疗费用
|
| | | | 71,709 | | |
|
应付帐款
|
| | | | 2,371 | | |
|
其他流动负债
|
| | | | 7,426 | | |
|
其他负债
|
| | | | 17 | | |
|
总负债
|
| | | | 81,523 | | |
|
已确认净资产收购
|
| | | | 53,196 | | |
|
商誉
|
| | | | 199,438 | | |
|
总购买考量
|
| | | $ | 252,634 | | |
| | |
预计合并损益表
(未审核) |
| |||||||||||||||||||||
| | |
截至3月31日的三个月
|
| |
截至2013年12月31日的年度
|
| ||||||||||||||||||
| | |
2021
|
| |
2020
|
| |
2020
|
| |
2019
|
| ||||||||||||
收入
|
| | | | $ 1,003,428 | | | | | | $ 330,438 | | | | | | $ 1,766,527 | | | | | | $ 769,722 | | |
净亏损
|
| | | | (13,531) | | | | | | (6,387) | | | | | | (221,023) | | | | | | (132,636) | | |
| | |
THNM
|
| |
Zipnosis
|
| ||||||
应收账款
|
| | | | $ 714 | | | | | | $ 1,062 | | |
短期投资
|
| | | | 4,677 | | | | | | $ — | | |
预付和其他流动资产
|
| | | | 8,337 | | | | | | 141 | | |
物业和设备
|
| | | | — | | | | | | 232 | | |
无形资产
|
| | | | 7,300 | | | | | | 8,970 | | |
长期投资
|
| | | | 13,081 | | | | | | — | | |
其他非流动资产
|
| | | | 1,324 | | | | | | 766 | | |
总资产
|
| | | | 35,433 | | | | | | 11,171 | | |
应付医疗费用
|
| | | | 13,268 | | | | | | — | | |
应付帐款
|
| | | | 14,663 | | | | | | 136 | | |
未赚取收入
|
| | | | 3,645 | | | | | | 120 | | |
其他流动负债
|
| | | | 2,682 | | | | | | 665 | | |
其他负债
|
| | | | 2,499 | | | | | | 2,730 | | |
总负债
|
| | | | 36,757 | | | | | | 3,651 | | |
已确认净资产收购
|
| | | | (1,324) | | | | | | 7,520 | | |
商誉
|
| | | | 4,739 | | | | | | 62,827 | | |
总购买考量
|
| | | | $ 3,415 | | | | | | $ 70,347 | | |
| | |
形式合并
损益表 (未审核) |
| |||||||||
| | |
2021
|
| |
2020
|
| ||||||
收入
|
| | | | $ 922,457 | | | | | | $ 233,210 | | |
净亏损
|
| | | | (27,133) | | | | | | (8,330) | | |
| | |
确认为
的金额
收购日期的 (如前所述) |
| |
测量
期间 调整 |
| |
确认为
的金额
收购日期的 (调整后) |
| |||||||||
应收账款
|
| | | | $ 74,128 | | | | | | $ — | | | | | | $ 74,128 | | |
预付和其他流动资产
|
| | | | 30,583 | | | | | | — | | | | | | 30,583 | | |
物业和设备
|
| | | | 4,375 | | | | | | — | | | | | | 4,375 | | |
无形资产
|
| | | | 72,600 | | | | | | 1,900 | | | | | | 74,500 | | |
其他非流动资产
|
| | | | 2,906 | | | | | | — | | | | | | 2,906 | | |
总资产
|
| | | | 184,592 | | | | | | 1,900 | | | | | | 186,492 | | |
应付医疗费用
|
| | | | 119,408 | | | | | | — | | | | | | 119,408 | | |
其他流动负债
|
| | | | 51,744 | | | | | | 174 | | | | | | 51,918 | | |
其他负债
|
| | | | 1,236 | | | | | | 108 | | | | | | 1,344 | | |
总负债
|
| | | | 172,388 | | | | | | 282 | | | | | | 172,670 | | |
已确认净资产收购
|
| | | | 12,204 | | | | | | 1,618 | | | | | | 13,822 | | |
商誉
|
| | | | 197,886 | | | | | | (1,618) | | | | | | 196,268 | | |
总购买考量
|
| | | | $ 210,090 | | | | | | $ — | | | | | | $ 210,090 | | |
| | |
2021年3月31日
|
| |||||||||||||||||||||
| | |
摊销
成本 |
| |
毛收入
未实现收益 |
| |
毛收入
未实现 亏损 |
| |
携带
值 |
| ||||||||||||
现金等价物
|
| | | | $ 233,427 | | | | | | $ — | | | | | | $ — | | | | | | $ 233,427 | | |
可供销售: | | | | | | | | | | | | | | | | | | | | | | | | | |
美国政府和机构的义务
|
| | | | 459,870 | | | | | | 1,165 | | | | | | (193) | | | | | | 460,842 | | |
公司义务
|
| | | | 219,839 | | | | | | 877 | | | | | | (90) | | | | | | 220,626 | | |
州和市政义务
|
| | | | 19,213 | | | | | | 86 | | | | | | — | | | | | | 19,299 | | |
商业票据
|
| | | | 4,996 | | | | | | 1 | | | | | | — | | | | | | 4,997 | | |
存单
|
| | | | 5,700 | | | | | | 1 | | | | | | — | | | | | | 5,701 | | |
抵押贷款支持证券
|
| | | | 3,035 | | | | | | 131 | | | | | | | | | | | | 3,166 | | |
其他
|
| | | | 1,100 | | | | | | — | | | | | | — | | | | | | 1,100 | | |
可供出售的证券总额
|
| | | | 713,753 | | | | | | 2,261 | | | | | | (283) | | | | | | 715,731 | | |
持有至到期: | | | | | | | | | | | | | | | | | | | | | | | | | |
美国政府和机构的义务
|
| | | | 7,220 | | | | | | — | | | | | | — | | | | | | 7,220 | | |
存单
|
| | | | 1,119 | | | | | | — | | | | | | — | | | | | | 1,119 | | |
持有至到期证券合计
|
| | | | 8,339 | | | | | | — | | | | | | — | | | | | | 8,339 | | |
总投资
|
| | | | $ 955,519 | | | | | | $ 2,261 | | | | | | $ (283) | | | | | | $ 957,497 | | |
| | |
2020年12月31日
|
| |||||||||||||||||||||
| | |
摊销
成本 |
| |
毛收入
未实现 收益 |
| |
毛收入
未实现 亏损 |
| |
携带
值 |
| ||||||||||||
现金等价物
|
| | | | $ 153,743 | | | | | | $ — | | | | | | $ (3) | | | | | | $ 153,740 | | |
可供销售: | | | | | | | | | | | | | | | | | | | | | | | | | |
美国政府和机构的义务
|
| | | | 291,834 | | | | | | 1,246 | | | | | | (1) | | | | | | 293,079 | | |
公司义务
|
| | | | 280,557 | | | | | | 1,104 | | | | | | (30) | | | | | | 281,631 | | |
州和市政义务
|
| | | | 18,459 | | | | | | 107 | | | | | | — | | | | | | 18,566 | | |
商业票据
|
| | | | 14,990 | | | | | | 1 | | | | | | — | | | | | | 14,991 | | |
存单
|
| | | | 53,504 | | | | | | 2 | | | | | | (1) | | | | | | 53,505 | | |
其他
|
| | | | 5,534 | | | | | | 2 | | | | | | — | | | | | | 5,536 | | |
可供出售的证券总额
|
| | | | 664,878 | | | | | | 2,462 | | | | | | (32) | | | | | | 667,308 | | |
持有至到期: | | | | | | | | | | | | | | | | | | | | | | | | | |
美国政府和机构的义务
|
| | | | 6,677 | | | | | | — | | | | | | — | | | | | | 6,677 | | |
存单
|
| | | | 1,119 | | | | | | — | | | | | | — | | | | | | 1,119 | | |
持有至到期证券合计
|
| | | | 7,796 | | | | | | — | | | | | | — | | | | | | 7,796 | | |
总投资
|
| | | | $ 826,417 | | | | | | $ 2,462 | | | | | | $ (35) | | | | | | $ 828,844 | | |
| | |
2021年3月31日
|
| |||||||||||||||||||||||||||||||||
| | |
不到12个月
|
| |
12个月或以上
|
| |
合计
|
| |||||||||||||||||||||||||||
投资说明
|
| |
公平
值 |
| |
未实现
亏损 |
| |
公平
值 |
| |
未实现
亏损 |
| |
公平
值 |
| |
未实现
亏损 |
| ||||||||||||||||||
美国政府和机构的义务
|
| | | | $ 204,999 | | | | | | $ (193) | | | | | | $ — | | | | | | $ — | | | | | | $ 204,999 | | | | | | $ (193) | | |
抵押贷款支持证券
|
| | | | 21 | | | | | | — | | | | | | | | | | | | | | | | | | 21 | | | | | | | | |
公司义务
|
| | | | 89,185 | | | | | | (90) | | | | | | — | | | | | | — | | | | | | 89,185 | | | | | | (90) | | |
存单
|
| | | | 700 | | | | | | — | | | | | | — | | | | | | — | | | | | | 700 | | | | | | — | | |
合计债券
|
| | | | $ 294,905 | | | | | | $ (283) | | | | | | $ — | | | | | | $ — | | | | | | $ 294,905 | | | | | | $ (283) | | |
| | |
2020年12月31日
|
| |||||||||||||||||||||||||||||||||
| | |
不到12个月
|
| |
12个月或以上
|
| |
合计
|
| |||||||||||||||||||||||||||
投资说明
|
| |
公平
值 |
| |
未实现
亏损 |
| |
公平
值 |
| |
未实现
亏损 |
| |
公平
值 |
| |
未实现
亏损 |
| ||||||||||||||||||
现金等价物
|
| | | | $ 25,007 | | | | | | $ (3) | | | | | | $ — | | | | | | $ — | | | | | | $ 25,007 | | | | | | $ (3) | | |
美国政府和机构的义务
|
| | | | 2,507 | | | | | | (1) | | | | | | — | | | | | | — | | | | | | 12,507 | | | | | | (1) | | |
公司义务
|
| | | | 121,006 | | | | | | (30) | | | | | | — | | | | | | — | | | | | | 121,006 | | | | | | (30) | | |
商业票据
|
| | | | 999 | | | | | | — | | | | | | — | | | | | | — | | | | | | 999 | | | | | | — | | |
存单
|
| | | | 14,003 | | | | | | (1) | | | | | | — | | | | | | — | | | | | | 14,003 | | | | | | (1) | | |
合计债券
|
| | | | $ 173,522 | | | | | | $ (35) | | | | | | $ — | | | | | | $ — | | | | | | $ 173,522 | | | | | | $ (35) | | |
| | |
摊销
成本 |
| |
公平
值 |
| ||||||
一年或更短时间内到期
|
| | | | $ 272,016 | | | | | | $ 272,809 | | |
一年至五年后到期
|
| | | | 441,248 | | | | | | 442,409 | | |
五年至十年后到期
|
| | | | 489 | | | | | | 513 | | |
10年后到期
|
| | | | — | | | | | | — | | |
总债务证券
|
| | | | $ 713,753 | | | | | | $ 715,731 | | |
| | |
2021年3月31日
|
| |||||||||||||||||||||
| | |
一级
|
| |
二级
|
| |
第三级
|
| |
合计
|
| ||||||||||||
资产 | | | | | | | | | | | | | | | | | | | | | | | | | |
现金等价物
|
| | | | $ 221,018 | | | | | | $ 625 | | | | | | $ — | | | | | | $ 221,643 | | |
可供销售:
|
| | | | | | | | | | | | | | | | | | | | | | | | |
美国政府和机构的义务
|
| | | | 320,911 | | | | | | 139,931 | | | | | | — | | | | | | 460,842 | | |
公司义务
|
| | | | 2,384 | | | | | | 218,242 | | | | | | — | | | | | | 220,626 | | |
州和市政义务
|
| | | | — | | | | | | 19,299 | | | | | | — | | | | | | 19,299 | | |
商业票据
|
| | | | — | | | | | | 4,997 | | | | | | — | | | | | | 4,997 | | |
存单
|
| | | | — | | | | | | 5,701 | | | | | | — | | | | | | 5,701 | | |
抵押贷款支持证券
|
| | | | 3,166 | | | | | | — | | | | | | — | | | | | | 3,166 | | |
其他
|
| | | | — | | | | | | 1,100 | | | | | | — | | | | | | 1,100 | | |
股权证券远期合约(1)
|
| | | | — | | | | | | 4,243 | | | | | | — | | | | | | 4,243 | | |
按公允价值计算的总资产
|
| | | | $ 547,479 | | | | | | $ 394,138 | | | | | | $ — | | | | | | $ 941,617 | | |
负债 | | | | | | | | | | | | | | | | | | | | | | | | | |
或有对价
|
| | | | $ — | | | | | | $ — | | | | | | $ 7,188 | | | | | | $ 7,188 | | |
| | |
2020年12月31日
|
| |||||||||||||||||||||
| | |
一级
|
| |
二级
|
| |
第三级
|
| |
合计
|
| ||||||||||||
资产 | | | | | | | | | | | | | | | | | | | | | | | | | |
现金等价物
|
| | | | $ 149,499 | | | | | | $ 4,019 | | | | | | $ — | | | | | | $ 153,518 | | |
可供销售:
|
| | | | | | | | | | | | | | | | | | | | | | | | |
美国政府和机构的义务
|
| | | | 197,886 | | | | | | 95,193 | | | | | | — | | | | | | 293,079 | | |
公司义务
|
| | | | — | | | | | | 281,631 | | | | | | — | | | | | | 281,631 | | |
州和市政义务
|
| | | | — | | | | | | 18,566 | | | | | | — | | | | | | 18,566 | | |
商业票据
|
| | | | — | | | | | | 14,991 | | | | | | — | | | | | | 14,991 | | |
存单
|
| | | | — | | | | | | 53,505 | | | | | | — | | | | | | 53,505 | | |
其他
|
| | | | — | | | | | | 5,536 | | | | | | — | | | | | | 5,536 | | |
按公允价值计算的总资产
|
| | | | $ 347,385 | | | | | | $ 473,441 | | | | | | $ — | | | | | | $ 820,826 | | |
负债
|
| | | | | | | | | | | | | | | | | | | | | | | | |
或有对价
|
| | | | $ — | | | | | | $ — | | | | | | $ 5,716 | | | | | | $ 5,716 | | |
| | |
2021年3月31日
|
| | | | | | | | | | |||||||||||||||||||||
| | |
一级
|
| |
二级
|
| |
第三级
|
| |
合计
|
| | | | ||||||||||||||||||
现金等价物
|
| | | | $ 11,784 | | | | | | $ — | | | | | | $ — | | | | | | $ 11,784 | | | | | | ||||||
持有至到期: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ||||||
美国政府和机构的义务
|
| | | | 7,220 | | | | | | — | | | | | | — | | | | | | 7,220 | | | | | | ||||||
存单
|
| | | | — | | | | | | 1,119 | | | | | | — | | | | | | 1,119 | | | | | | ||||||
持有至到期的合计
|
| | | | $ 19,004 | | | | | | $ 1,119 | | | | | | $ — | | | | | | $ 20,123 | | | | | |
| | |
2020年12月31日
|
| |||||||||||||||||||||
| | |
一级
|
| |
二级
|
| |
第三级
|
| |
合计
|
| ||||||||||||
现金等价物
|
| | | | $ 222 | | | | | | $ — | | | | | | $ — | | | | | | $ 222 | | |
持有至到期: | | | | | | | | | | | | | | | | | | | | | | | | | |
美国政府和机构的义务
|
| | | | 6,732 | | | | | | — | | | | | | — | | | | | | 6,732 | | |
存单
|
| | | | — | | | | | | 1,119 | | | | | | — | | | | | | 1,119 | | |
持有至到期的合计
|
| | | | $ 6,954 | | | | | | $ 1,119 | | | | | | $ — | | | | | | $ 8,073 | | |
| | |
2021
|
| |
2020
|
| ||||||
期初余额
|
| | | | $ 5,716 | | | | | | $ 5,716 | | |
或有对价公允价值变动
|
| | | | 1,472 | | | | | | — | | |
期末余额
|
| | | | $ 7,188 | | | | | | $ 5,716 | | |
| | |
光明医疗
|
| |
NeueHealth
|
| ||||||||||||||||||
| | |
毛收入
金额 |
| |
累计
减损 |
| |
毛收入
金额 |
| |
累计
减损 |
| ||||||||||||
2020年12月31日的余额
|
| | | | $ 197,886 | | | | | | $ — | | | | | | $ 65,149 | | | | | | $ — | | |
收购
|
| | | | 4,739 | | | | | | | | | | | | 62,827 | | | | | | | | |
采购调整
|
| | | | (1,618) | | | | | | | | | | | | — | | | | | | | | |
2021年3月31日的余额
|
| | | | $ 201,007 | | | | | | $ — | | | | | | $ 127,976 | | | | | | $ — | | |
| | |
2021年3月31日
|
| |
2020年12月31日
|
| ||||||||||||||||||
| | |
毛收入
金额 |
| |
累计
摊销 |
| |
毛收入
金额 |
| |
累计
摊销 |
| ||||||||||||
客户关系
|
| | | | $ 123,751 | | | | | | $ 6,590 | | | | | | $ 117,451 | | | | | | $ 3,664 | | |
商品名称
|
| | | | 42,831 | | | | | | 2,283 | | | | | | 38,161 | | | | | | 1,604 | | |
开发的技术
|
| | | | 6,200 | | | | | | | | | | | | | | | | | | | | |
其他
|
| | | | 3,000 | | | | | | 183 | | | | | | 2,000 | | | | | | 133 | | |
合计
|
| | | | $ 175,782 | | | | | | $ 9,056 | | | | | | $ 157,612 | | | | | | $ 5,401 | | |
| | |
公允价值
|
| |
加权平均
使用寿命 (单位:年) |
| ||||||
客户关系
|
| | | | $ 5,100 | | | | | | 14.3 | | |
商品名称
|
| | | | 3.970 | | | | | | 13.1 | | |
开发的技术
|
| | | | 6,200 | | | | | | 7.0 | | |
其他
|
| | | | 1,000 | | | | | | 7.0 | | |
合计
|
| | | | $ 16,270 | | | | | | 10.8 | | |
|
2021年(4月 - 12月)
|
| | | | $ 11,984 | | |
|
2022
|
| | | | 15,979 | | |
|
2023
|
| | | | 15,979 | | |
|
2024
|
| | | | 15,979 | | |
|
2025
|
| | | | 15,979 | | |
|
2026
|
| | | | 15,864 | | |
| | |
2021
|
| |
2020
|
| ||||||
1月1日 - 应付医疗费用
|
| | | | $ 249,777 | | | | | | $ 44,804 | | |
发生的费用与:
|
| | | | | | | | | | | | |
本年度
|
| | | | 689,572 | | | | | | 141,065 | | |
上一年
|
| | | | (3,076) | | | | | | (8,324) | | |
已发生的总费用
|
| | | | 686,496 | | | | | | 132,741 | | |
付款对象:
|
| | | | | | | | | | | | |
本年度
|
| | | | 307,442 | | | | | | 55,980 | | |
上一年
|
| | | | 153,240 | | | | | | 22,939 | | |
支付总额
|
| | | | 460,682 | | | | | | 78,919 | | |
获得的索赔负债
|
| | | | 13,268 | | | | | | — | | |
3月31日 - 应付医疗费用
|
| | | | $ 488,859 | | | | | | $ 98,626 | | |
| | |
2021
|
| |
2020
|
| ||||||
未付索赔
|
| | | | $ 19,652 | | | | | | $ 2,326 | | |
应付风险分担金额
|
| | | | 36,592 | | | | | | 3,564 | | |
索赔调整费用负债
|
| | | | 5,038 | | | | | | 3,283 | | |
已发生但未报告(IBNR)
|
| | | | 427,577 | | | | | | 89,453 | | |
应付医疗费用总额
|
| | | | $ 488,859 | | | | | | $ 98,626 | | |
| | |
2021
|
| |
2020
|
| ||||||
无风险利率
|
| | | | 0.77% | | | | | | 1.45% | | |
预期波动率
|
| | | | 33.3% | | | | | | 29.0% | | |
预期股息率
|
| | | | 0.0% | | | | | | 0.0% | | |
失败率
|
| | | | 14.5% | | | | | | 14.5% | | |
预期寿命(以年计)
|
| | | | 6.1 | | | | | | 6.1 | | |
| | |
个共享
|
| |
加权-
平均 练习 价格 |
| |
加权平均
剩余 合同期限 (年) |
| |
聚合
内在价值 |
| ||||||||||||
2021年1月1日业绩突出
|
| | | | 63,925 | | | | | | 1.47 | | | | | | 8.7 | | | | | | $ 53,573 | | |
已批准
|
| | | | 17,772 | | | | | | 2.30 | | | | | | | | | | | | | | |
锻炼
|
| | | | (4,661) | | | | | | 0.97 | | | | | | | | | | | | | | |
被没收
|
| | | | (123) | | | | | | 1.62 | | | | | | | | | | | | | | |
已过期
|
| | | | — | | | | | | — | | | | | | | | | | | | | | |
2021年3月31日业绩突出
|
| | | | 76,913 | | | | | | $ 1.69 | | | | | | 8.9 | | | | | | $861,932 | | |
| | |
2021
|
| |
2020
|
| ||||||
光明健康集团普通股股东应占净亏损
|
| | | | $ (25,162) | | | | | | $ (7,280) | | |
加权平均流通股数量用于计算每股净亏损
普通股股东,基本和稀释 |
| | | | 140,175 | | | | | | 137,125 | | |
普通股股东每股净亏损,基本股和
稀释 |
| | | | $ (0.18) | | | | | | $ (0.05) | | |
| | |
2021
|
| |
2020
|
| ||||||
可赎回优先股
|
| | | | 421,697 | | | | | | 282,367 | | |
购买普通股的股票期权
|
| | | | 76,913 | | | | | | 50,573 | | |
合计
|
| | | | 498,610 | | | | | | 332,940 | | |
截至2021年3月31日的三个月
|
| |
明亮
医疗保健 |
| |
NeueHealth
|
| |
消除
|
| |
合并
|
| ||||||||||||
保费收入
|
| | | | $ 841,925 | | | | | | $ 18,706 | | | | | | $ — | | | | | | $ 860,631 | | |
服务收入
|
| | | | — | | | | | | 8,438 | | | | | | — | | | | | | 8,438 | | |
投资收益
|
| | | | 1,246 | | | | | | 4,243 | | | | | | — | | | | | | 5,489 | | |
无关联总收入
|
| | | | 843,171 | | | | | | 31,387 | | | | | | — | | | | | | 874,558 | | |
关联收入
|
| | | | — | | | | | | 17,152 | | | | | | (17,152) | | | | | | — | | |
部门总收入
|
| | | | 843,171 | | | | | | 48,539 | | | | | | (17,152) | | | | | | 874,558 | | |
营业亏损
|
| | | | (24,215) | | | | | | 1,382 | | | | | | — | | | | | | (22,833) | | |
折旧摊销
|
| | | | $ 2,357 | | | | | | $ 2,224 | | | | | | $ — | | | | | | $ 4,581 | | |
截至2020年3月31日的三个月
|
| |
明亮
医疗保健 |
| |
NeueHealth
|
| |
消除
|
| |
合并
|
| ||||||||||||
保费收入
|
| | | | $ 188,733 | | | | | | $ 2,004 | | | | | | $ — | | | | | | $ 190,737 | | |
服务收入
|
| | | | — | | | | | | 4,820 | | | | | | — | | | | | | 4,820 | | |
投资收益
|
| | | | 3,009 | | | | | | — | | | | | | — | | | | | | 3,009 | | |
总收入
|
| | | | 191,742 | | | | | | 6,824 | | | | | | — | | | | | | 198,566 | | |
关联收入
|
| | | | — | | | | | | 2,707 | | | | | | (2,707) | | | | | | — | | |
部门总收入
|
| | | | 191,742 | | | | | | 9,531 | | | | | | (2,707) | | | | | | 198,566 | | |
营业亏损
|
| | | | (6,110) | | | | | | (1,170) | | | | | | — | | | | | | (7,280) | | |
折旧摊销
|
| | | | $ 262 | | | | | | $ 525 | | | | | | $ — | | | | | | $ 787 | | |
| | |
可赎回
非控制性 利息 |
| |||
2021年1月1日的余额
|
| | | | $ 39,600 | | |
非控股权益收益
|
| | | | 288 | | |
测量调整
|
| | | | 329 | | |
2021年3月31日的余额
|
| | | | $ 40,217 | | |
| | |
作为
之前的 报告 |
| |
调整
|
| |
如上所述
|
| |||||||||
截至2021年3月31日的简明合并资产负债表 | | | | | | | | | | | | | | | | | | | |
商誉
|
| | | $ | 306,828 | | | | | $ | 22,155 | | | | | $ | 328,983 | | |
可赎回优先股
|
| | | | 1,713,997 | | | | | | 22,155 | | | | | | 1,736,152 | | |
新增实收资本
|
| | | | 16,904 | | | | | | 3,042 | | | | | | 19,946 | | |
累计亏损
|
| | | | (538,109) | | | | | | (3,042) | | | | | | (541,151) | | |
截至2021年3月31日的三个月简明合并损益表
|
| | | | | | | | | | | | | | | | | | |
运营成本
|
| | | | 205,198 | | | | | | 3,042 | | | | | | 208,240 | | |
净亏损
|
| | | | (21,503) | | | | | | (3,042) | | | | | | (24,545) | | |
光明健康集团普通股股东应占净亏损
|
| | | | (22,120) | | | | | | (3,042) | | | | | | (25,162) | | |
截至2021年3月31日的三个月简明综合全面收益(亏损)表
|
| | | | | | | | | | | | | | | | | | |
净亏损
|
| | | | (21,503) | | | | | | (3,042) | | | | | | (24,545) | | |
光明健康集团普通股股东应占综合亏损
|
| | | | (23,162) | | | | | | (3,042) | | | | | | (26,204) | | |
截至2021年3月31日的三个月可赎回优先股和股东赤字变化简明综合报表
|
| | | | | | | | | | | | | | | | | | |
净亏损
|
| | | | (22,120) | | | | | | (3,042) | | | | | | (25,162) | | |
优先股发行
|
| | | | 32,982 | | | | | | 22,155 | | | | | | 55,137 | | |
基于股份的薪酬
|
| | | | 2,134 | | | | | | 3,042 | | | | | | 5,176 | | |
截至2021年3月31日的三个月简明合并现金流量表
|
| | | | | | | | | | | | | | | | | | |
净亏损
|
| | | | (22,120) | | | | | | (3,042) | | | | | | (25,162) | | |
基于股份的薪酬
|
| | | | 2,134 | | | | | | 3,042 | | | | | | 5,176 | | |
| | |
截至12月31日
|
| |||||||||
| | |
2020
|
| |
2019
|
| ||||||
资产 | | | | | | | | | | | | | |
流动资产: | | | | | | | | | | | | | |
现金和现金等价物
|
| | | | $ 488,371 | | | | | | $ 522,910 | | |
短期投资
|
| | | | 499,928 | | | | | | 107,682 | | |
应收账款,扣除备用金分别为2602美元和287美元
|
| | | | 60,522 | | | | | | 787 | | |
预付和其他流动资产
|
| | | | 130,986 | | | | | | 17,221 | | |
流动资产总额
|
| | | | 1,179,807 | | | | | | 648,600 | | |
其他资产: | | | | | | | | | | | | | |
长期投资
|
| | | | 175,176 | | | | | | 115,348 | | |
财产、设备和大写软件,净额
|
| | | | 12,264 | | | | | | 3,231 | | |
商誉
|
| | | | 263,035 | | | | | | 20,125 | | |
无形资产净值
|
| | | | 152,211 | | | | | | 18,712 | | |
其他非流动资产
|
| | | | 28,309 | | | | | | 14,339 | | |
其他资产合计
|
| | | | 630,995 | | | | | | 171,755 | | |
总资产
|
| | | | $ 1,810,802 | | | | | | $ 820,355 | | |
负债、可赎回非控股权益、可赎回优先股
和股东亏损 |
| | | | | | | | | | | | |
流动负债: | | | | | | | | | | | | | |
应付医疗费用
|
| | | | $ 249,777 | | | | | | $ 44,804 | | |
应付帐款
|
| | | | 57,252 | | | | | | 33,143 | | |
未赚取收入
|
| | | | 34,628 | | | | | | 16,005 | | |
应付风险调整
|
| | | | 187,777 | | | | | | 86,803 | | |
其他流动负债
|
| | | | 35,847 | | | | | | 14,140 | | |
流动负债总额
|
| | | | 565,281 | | | | | | 194,895 | | |
其他负债
|
| | | | 28,578 | | | | | | 16,837 | | |
总负债
|
| | | | 593,859 | | | | | | 211,732 | | |
承付款和或有事项(附注14) | | | | | | | | | | | | | |
可赎回的非控股权益
|
| | | | 39,600 | | | | | | — | | |
可赎回优先股,面值0.0001美元;166,307,087股和152,878,225股
分别于2020年和2019年授权;已发行164,244,893股和119,221,767股; 2020年和2019年分别突出 |
| | | | 1,681,015 | | | | | | 871,990 | | |
股东亏损: | | | | | | | | | | | | | |
普通股,面值0.0001美元;2020年授权658,993,725股和563,612,706股
和2019年分别为137,662,698股和135,509,085股 2020年和2019年分别 |
| | | | 14 | | | | | | 14 | | |
新增实收资本
|
| | | | 9,877 | | | | | | 3,184 | | |
累计亏损
|
| | | | (515,989) | | | | | | (267,547) | | |
累计其他综合收益(亏损)
|
| | | | 2,426 | | | | | | 982 | | |
股东亏损总额
|
| | | | (503,672) | | | | | | (263,367) | | |
总负债、可赎回非控股权益、可赎回优先股和股东亏损
|
| | | | $ 1,810,802 | | | | | | $ 820,355 | | |
| | |
截至2013年12月31日的年度
|
| |||||||||||||||
| | |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
收入: | | | | | | | | | | | | | | | | | | | |
保费收入
|
| | | | $ 1,180,338 | | | | | | $ 272,323 | | | | | | $ 127,122 | | |
服务收入
|
| | | | 18,514 | | | | | | — | | | | | | — | | |
投资收益
|
| | | | 8,468 | | | | | | 8,350 | | | | | | 3,510 | | |
总收入
|
| | | | 1,207,320 | | | | | | 280,673 | | | | | | 130,632 | | |
运营成本: | | | | | | | | | | | | | | | | | | | |
医疗费用
|
| | | | 1,047,300 | | | | | | 224,387 | | | | | | 96,407 | | |
运营成本
|
| | | | 409,334 | | | | | | 180,489 | | | | | | 95,836 | | |
折旧摊销
|
| | | | 8,289 | | | | | | 1,134 | | | | | | 1,030 | | |
总运营成本
|
| | | | 1,464,923 | | | | | | 406,010 | | | | | | 193,273 | | |
所得税前亏损
|
| | | | (257,603) | | | | | | (125,337) | | | | | | (62,641) | | |
所得税(福利)费用
|
| | | | (9,161) | | | | | | — | | | | | | — | | |
净亏损
|
| | | | $ (248,442) | | | | | | $ (125,337) | | | | | | $ (62,641) | | |
光明健康公司普通股股东应占每股基本和摊薄亏损
|
| | | | $ (1.82) | | | | | | $ (0.93) | | | | | | $ (0.47) | | |
已发行基本和稀释加权平均普通股
|
| | | | 136,193 | | | | | | 134,486 | | | | | | 131,975 | | |
| | |
截至2013年12月31日的年度
|
| |||||||||||||||
| | |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
净亏损
|
| | | | $ (248,442) | | | | | | $ (125,337) | | | | | | $ (62,641) | | |
其他综合收益(亏损): | | | | | | | | | | | | | | | | | | | |
本年度产生的未实现投资持有收益,
税净额分别为0美元、0美元和0美元 |
| | | | 1,556 | | | | | | 1,211 | | | | | | 72 | | |
减去:投资损益重分类调整,
税净额分别为0美元、0美元和0美元 |
| | | | 112 | | | | | | 38 | | | | | | (17) | | |
其他综合收益
|
| | | | 1,444 | | | | | | 1,173 | | | | | | 89 | | |
全面亏损
|
| | | | $ (246,998) | | | | | | $ (124,164) | | | | | | $ (62,552) | | |
| | |
可赎回优先股
|
| | |
普通股
|
| |
其他
实收 大写 |
| |
保留
收入 (赤字) |
| |
累计
其他 综合 收入(亏损) |
| |
合计
|
| ||||||||||||||||||||||||||||||
| | |
个共享
|
| |
金额
|
| | |
个共享
|
| |
金额
|
| ||||||||||||||||||||||||||||||||||||
2018年1月1日余额
|
| | | | 64,122 | | | | | | $ 241,690 | | | | | | | 130,262 | | | | | | $ 13 | | | | | | $ 746 | | | | | | $ (79,498) | | | | | | $ (280) | | | | | | $ (79,019) | | |
净亏损
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | (62,641) | | | | | | — | | | | | | (62,641) | | |
优先股发行
|
| | | | 26,660 | | | | | | 203,000 | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
普通股发行
|
| | | | — | | | | | | — | | | | | | | 3,864 | | | | | | — | | | | | | 57 | | | | | | — | | | | | | — | | | | | | 57 | | |
基于股份的薪酬
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | 257 | | | | | | — | | | | | | — | | | | | | 257 | | |
其他综合收益
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 89 | | | | | | 89 | | |
2018年12月31日的余额
|
| | | | 90,782 | | | | | | 444,690 | | | | | | | 134,126 | | | | | | 13 | | | | | | 1,060 | | | | | | (142,139) | | | | | | (191) | | | | | | (141,257) | | |
采用会计准则的影响
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | (71) | | | | | | — | | | | | | (71) | | |
净亏损
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | (125,337) | | | | | | — | | | | | | (125,337) | | |
优先股发行
|
| | | | 28,440 | | | | | | 427,300 | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
普通股发行
|
| | | | — | | | | | | — | | | | | | | 1,383 | | | | | | 1 | | | | | | 260 | | | | | | — | | | | | | — | | | | | | 261 | | |
基于股份的薪酬
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | 1,864 | | | | | | — | | | | | | — | | | | | | 1,864 | | |
其他综合收益
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 1,173 | | | | | | 1,173 | | |
2019年12月31日的余额
|
| | | | 119,222 | | | | | | 871,990 | | | | | | | 135,509 | | | | | | 14 | | | | | | 3,184 | | | | | | (267,547) | | | | | | 982 | | | | | | (263,367) | | |
净亏损
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | (248,442) | | | | | | — | | | | | | (248,442) | | |
优先股发行
|
| | | | 45,023 | | | | | | 809,025 | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
普通股发行
|
| | | | — | | | | | | — | | | | | | | 2,154 | | | | | | — | | | | | | 1,241 | | | | | | — | | | | | | — | | | | | | 1,241 | | |
基于股份的薪酬
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | 5,452 | | | | | | — | | | | | | — | | | | | | 5,452 | | |
其他综合收益
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 1,444 | | | | | | 1,444 | | |
2020年12月31日的余额
|
| | | | 164,245 | | | | | | $ 1,681,015 | | | | | | | 137,663 | | | | | | $ 14 | | | | | | $ 9,877 | | | | | | $ (515,989) | | | | | | $ 2,426 | | | | | | $ (503,672) | | |
| | |
截至2013年12月31日的年度
|
| |||||||||||||||
| | |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
经营活动现金流: | | | | | | | | | | | | | | | | | | | |
净亏损
|
| | | | $ (248,442) | | | | | | $ (125,337) | | | | | | $ (62,641) | | |
调整以调整净亏损与经营活动中使用的净现金:
|
| | | | | | | | | | | | | | | | | | |
折旧摊销
|
| | | | 8,289 | | | | | | 1,134 | | | | | | 1,030 | | |
基于股份的薪酬
|
| | | | 5,452 | | | | | | 1,864 | | | | | | 257 | | |
其他,净额
|
| | | | 2,667 | | | | | | (1,331) | | | | | | 89 | | |
资产负债变动:
|
| | | | — | | | | | | — | | | | | | — | | |
应收账款
|
| | | | 24,631 | | | | | | (201) | | | | | | (568) | | |
其他资产
|
| | | | (44,061) | | | | | | (8,788) | | | | | | (3,697) | | |
应付医疗费用
|
| | | | 78,591 | | | | | | 21,826 | | | | | | 17,133 | | |
应付帐款和其他负债
|
| | | | 97,012 | | | | | | 95,690 | | | | | | 17,948 | | |
未赚取收入
|
| | | | 18,623 | | | | | | 6,935 | | | | | | 3,415 | | |
经营活动使用的净现金
|
| | | | (57,238) | | | | | | (8,208) | | | | | | (27,034) | | |
投资活动现金流: | | | | | | | | | | | | | | | | | | | |
购买投资
|
| | | | (916,823) | | | | | | (300,325) | | | | | | (166,817) | | |
投资的销售、支付和到期日收益
|
| | | | 463,887 | | | | | | 238,330 | | | | | | 160,571 | | |
购置房产和设备
|
| | | | (6,474) | | | | | | (793) | | | | | | (694) | | |
业务收购,扣除收购现金后的净额
|
| | | | (230,332) | | | | | | (31,855) | | | | | | — | | |
投资活动使用的净现金
|
| | | | (689,742) | | | | | | (94,643) | | | | | | (6,940) | | |
融资活动现金流: | | | | | | | | | | | | | | | | | | | |
普通股发行收益
|
| | | | 1,241 | | | | | | 260 | | | | | | 57 | | |
优先股发行收益
|
| | | | 711,200 | | | | | | 423,800 | | | | | | 203,000 | | |
融资活动提供的净现金
|
| | | | 712,441 | | | | | | 424,060 | | | | | | 203,057 | | |
现金及现金等价物净增(减)
|
| | | | (34,539) | | | | | | 321,209 | | | | | | 169,083 | | |
年初 - 现金和现金等价物
|
| | | | 522,910 | | | | | | 201,701 | | | | | | 32,618 | | |
现金和现金等价物 - 年终
|
| | | | $ 488,371 | | | | | | $ 522,910 | | | | | | $ 201,701 | | |
现金流量信息补充披露: | | | | | | | | | | | | | | | | | | | |
OCI中可供出售证券的未实现收益变化
|
| | | | $ 1,444 | | | | | | $ 1,173 | | | | | | $ 89 | | |
非现金投资活动补充日程表: | | | | | | | | | | | | | | | | | | | |
为收购而发行的可赎回优先股
|
| | | | $ 97,825 | | | | | | $ 3,500 | | | | | | $ — | | |
或有对价
|
| | | | — | | | | | | 5,716 | | | | | | — | | |
| | |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
薪酬和附带福利
|
| | | | $ 133,009 | | | | | | $ 50,325 | | | | | | $ 30,037 | | |
专业费
|
| | | | 78,740 | | | | | | 40,601 | | | | | | 24,446 | | |
技术 | | | | | 19,433 | | | | | | 7,243 | | | | | | 2,541 | | |
营销和销售费用
|
| | | | 96,942 | | | | | | 49,711 | | | | | | 26,750 | | |
其他运营费用
|
| | | | 81,210 | | | | | | 32,609 | | | | | | 12,062 | | |
总运营成本
|
| | | | $ 409,334 | | | | | | $ 180,489 | | | | | | $ 95,836 | | |
|
应收账款
|
| | | | $ 10,238 | | |
|
预付和其他流动资产
|
| | | | 76 | | |
|
物业和设备
|
| | | | 1,071 | | |
|
无形资产
|
| | | | 66,300 | | |
|
其他非流动资产
|
| | | | 6,468 | | |
|
总资产
|
| | | | 84,153 | | |
|
应付医疗费用
|
| | | | 6,973 | | |
|
其他流动负债
|
| | | | 3,004 | | |
|
其他负债
|
| | | | 5,534 | | |
|
总负债
|
| | | | 15,511 | | |
|
已确认净资产收购
|
| | | | 68,642 | | |
|
商誉
|
| | | | 45,142 | | |
|
可赎回的非控股权益
|
| | | | (39,600) | | |
|
总购买考量
|
| | | | $ 74,184 | | |
| | |
形式合并
损益表 (未审核) |
| |||||||||
| | |
2020
|
| |
2019
|
| ||||||
收入 | | | | | $ 1,293,923 | | | | | | $ 359,074 | | |
净亏损
|
| | | | (239,907) | | | | | | (123,415) | | |
|
应收账款
|
| | | | $ 74,128 | | |
|
预付和其他流动资产
|
| | | | 30,583 | | |
|
物业和设备
|
| | | | 4,375 | | |
|
无形资产
|
| | | | 72,600 | | |
|
其他非流动资产
|
| | | | 2,906 | | |
|
总资产
|
| | | | 184,592 | | |
|
应付医疗费用
|
| | | | 119,408 | | |
|
其他流动负债
|
| | | | 42,356 | | |
|
其他负债
|
| | | | 10,624 | | |
|
总负债
|
| | | | 172,388 | | |
|
已确认净资产收购
|
| | | | 12,204 | | |
|
商誉
|
| | | | 197,886 | | |
|
总购买考量
|
| | | | $ 210,090 | | |
| | |
形式合并
损益表 (未审核) |
| |||||||||
| | |
2020
|
| |
2019
|
| ||||||
收入 | | | | | $ 1,403,483 | | | | | | $ 776,751 | | |
净亏损
|
| | | | (264,400) | | | | | | (173,439) | | |
|
预付和其他流动资产
|
| | | | $ 2,725 | | |
|
物业和设备
|
| | | | 1,341 | | |
|
无形资产
|
| | | | 18,712 | | |
|
其他非流动资产
|
| | | | 3,962 | | |
|
总资产
|
| | | | 26,740 | | |
|
其他流动负债
|
| | | | 2,776 | | |
|
其他负债
|
| | | | 3,018 | | |
|
总负债
|
| | | | 5,794 | | |
|
已确认净资产收购
|
| | | | 20,946 | | |
|
商誉
|
| | | | 20,007 | | |
|
采购总价
|
| | | | $ 40,953 | | |
| | |
形式合并
损益表 (未审核) |
| |||||||||
| | |
2019
|
| |
2018
|
| ||||||
收入 | | | | | $ 310,092 | | | | | | $ 155,196 | | |
净亏损
|
| | | | (125,565) | | | | | | (63,416) | | |
| | |
2020
|
| |||||||||||||||||||||
| | |
摊销
成本 |
| |
毛收入
未实现 收益 |
| |
毛收入
未实现 亏损 |
| |
携带
值 |
| ||||||||||||
现金等价物
|
| | | | $ 153,743 | | | | | | $ — | | | | | | $ (3) | | | | | | $ 153,740 | | |
可供销售: | | | | | | | | | | | | | | | | | | | | | | | | | |
美国政府和机构的义务
|
| | | | 291,834 | | | | | | 1,246 | | | | | | (1) | | | | | | 293,079 | | |
公司义务
|
| | | | 280,557 | | | | | | 1,104 | | | | | | (30) | | | | | | 281,631 | | |
州和市政义务
|
| | | | 18,459 | | | | | | 107 | | | | | | — | | | | | | 18,566 | | |
商业票据
|
| | | | 14,990 | | | | | | 1 | | | | | | — | | | | | | 14,991 | | |
存单
|
| | | | 53,504 | | | | | | 2 | | | | | | (1) | | | | | | 53,505 | | |
其他
|
| | | | 5,534 | | | | | | 2 | | | | | | — | | | | | | 5,536 | | |
可供出售的证券总额
|
| | | | 664,878 | | | | | | 2,462 | | | | | | (32) | | | | | | 667,308 | | |
持有至到期: | | | | | | | | | | | | | | | | | | | | | | | | | |
美国政府和机构的义务
|
| | | | 6,677 | | | | | | — | | | | | | — | | | | | | 6,677 | | |
存单
|
| | | | 1,119 | | | | | | — | | | | | | — | | | | | | 1,119 | | |
持有至到期证券合计
|
| | | | 7,796 | | | | | | — | | | | | | — | | | | | | 7,796 | | |
总投资
|
| | | | $ 826,417 | | | | | | $ 2,462 | | | | | | $ (35) | | | | | | $ 828,844 | | |
| | |
2019
|
| |||||||||||||||||||||
| | |
摊销
成本 |
| |
毛收入
未实现 收益 |
| |
毛收入
未实现 亏损 |
| |
携带
值 |
| ||||||||||||
现金等价物
|
| | | | $ 444,314 | | | | | | $ 1 | | | | | | $ — | | | | | | $ 444,315 | | |
可供销售: | | | | | | | | | | | | | | | | | | | | | | | | | |
美国政府和机构的义务
|
| | | | 143,746 | | | | | | 638 | | | | | | (10) | | | | | | 144,374 | | |
公司义务
|
| | | | 69,034 | | | | | | 353 | | | | | | (4) | | | | | | 69,383 | | |
资产支持证券
|
| | | | 2,501 | | | | | | 4 | | | | | | — | | | | | | 2,505 | | |
可供出售的证券总额
|
| | | | 215,281 | | | | | | 995 | | | | | | (14) | | | | | | 216,262 | | |
持有至到期: | | | | | | | | | | | | | | | | | | | | | | | | | |
美国政府和机构的义务
|
| | | | 5,577 | | | | | | — | | | | | | — | | | | | | 5,577 | | |
存单
|
| | | | 1,191 | | | | | | — | | | | | | — | | | | | | 1,191 | | |
持有至到期证券合计
|
| | | | 6,768 | | | | | | — | | | | | | — | | | | | | 6,768 | | |
总投资
|
| | | | $ 666,363 | | | | | | $ 996 | | | | | | $ (14) | | | | | | $ 667,345 | | |
| | |
2020年12月31日
|
| |||||||||||||||||||||||||||||||||
| | |
不到12个月
|
| |
12个月或以上
|
| |
合计
|
| |||||||||||||||||||||||||||
投资说明
|
| |
公平
值 |
| |
未实现
亏损 |
| |
公平
值 |
| |
未实现
亏损 |
| |
公平
值 |
| |
未实现
亏损 |
| ||||||||||||||||||
现金等价物
|
| | | | $ 25,007 | | | | | | $ (3) | | | | | | $ — | | | | | | $ — | | | | | | $ 25,007 | | | | | | $ (3) | | |
美国政府和机构的义务
|
| | | | 12,507 | | | | | | (1) | | | | | | — | | | | | | — | | | | | | 12,507 | | | | | | (1) | | |
公司义务
|
| | | | 121,006 | | | | | | (30) | | | | | | — | | | | | | — | | | | | | 121,006 | | | | | | (30) | | |
商业票据
|
| | | | 999 | | | | | | — | | | | | | — | | | | | | — | | | | | | 999 | | | | | | — | | |
存单
|
| | | | 14,003 | | | | | | (1) | | | | | | — | | | | | | — | | | | | | 14,003 | | | | | | (1) | | |
合计债券
|
| | | | $ 173,522 | | | | | | $ (35) | | | | | | $ — | | | | | | $ — | | | | | | $ 173,522 | | | | | | $ (35) | | |
| | |
2019年12月31日
|
| |||||||||||||||||||||||||||||||||
| | |
不到12个月
|
| |
12个月或以上
|
| |
合计
|
| |||||||||||||||||||||||||||
投资说明
|
| |
公平
值 |
| |
未实现
亏损 |
| |
公平
值 |
| |
未实现
亏损 |
| |
公平
值 |
| |
未实现
亏损 |
| ||||||||||||||||||
美国政府和机构的义务
|
| | | | 8,469 | | | | | | (9) | | | | | | 1,645 | | | | | | (1) | | | | | | 10,114 | | | | | | (10) | | |
公司义务
|
| | | | 5,498 | | | | | | (4) | | | | | | — | | | | | | — | | | | | | 5,498 | | | | | | (4) | | |
合计债券
|
| | | | $ 13,967 | | | | | | $ (13) | | | | | | $ 1,645 | | | | | | $ (1) | | | | | | $ 15,612 | | | | | | $ (14) | | |
| | |
2020
|
| |||||||||
| | |
摊销
成本 |
| |
公平
值 |
| ||||||
一年或更短时间内到期
|
| | | | $ 497,885 | | | | | | $ 498,865 | | |
一年至五年后到期
|
| | | | 165,793 | | | | | | 167,242 | | |
五年至十年后到期
|
| | | | — | | | | | | — | | |
10年后到期
|
| | | | 1,200 | | | | | | 1,200 | | |
总债务证券
|
| | | | $ 664,878 | | | | | | $ 667,307 | | |
| | |
2020
|
| |||||||||||||||||||||
| | |
一级
|
| |
二级
|
| |
第三级
|
| |
合计
|
| ||||||||||||
现金等价物
|
| | | | $ 149,499 | | | | | | $ 4,019 | | | | | | $ — | | | | | | $ 153,518 | | |
可供销售: | | | | | | | | | | | | | | | | | | | | | | | | | |
美国政府和机构的义务
|
| | | | 197,886 | | | | | | 95,193 | | | | | | — | | | | | | 293,079 | | |
公司义务
|
| | | | — | | | | | | 281,631 | | | | | | — | | | | | | 281,631 | | |
州和市政义务
|
| | | | — | | | | | | 18,566 | | | | | | — | | | | | | 18,566 | | |
商业票据
|
| | | | — | | | | | | 14,991 | | | | | | — | | | | | | 14,991 | | |
存单
|
| | | | — | | | | | | 53,505 | | | | | | — | | | | | | 53,505 | | |
其他
|
| | | | — | | | | | | 5,536 | | | | | | — | | | | | | 5,536 | | |
按公允价值计算的总资产
|
| | | | $ 347,385 | | | | | | $ 473,441 | | | | | | $ — | | | | | | $ 820,826 | | |
负债 | | | | | | | | | | | | | | | | | | | | | | | | | |
或有对价
|
| | | | $ — | | | | | | $ — | | | | | | $ 5,716 | | | | | | $ 5,716 | | |
| | |
2019
|
| |||||||||||||||||||||
| | |
一级
|
| |
二级
|
| |
第三级
|
| |
合计
|
| ||||||||||||
现金等价物
|
| | | | $ 444,215 | | | | | | $ 100 | | | | | | $ — | | | | | | $ 444,315 | | |
可供销售: | | | | | | | | | | | | | | | | | | | | | | | | | |
美国政府和机构的义务
|
| | | | 95,149 | | | | | | 49,225 | | | | | | — | | | | | | 144,374 | | |
公司义务
|
| | | | — | | | | | | 69,383 | | | | | | — | | | | | | 69,383 | | |
资产支持证券
|
| | | | — | | | | | | 2,505 | | | | | | — | | | | | | 2,505 | | |
按公允价值计算的总资产
|
| | | | $ 539,364 | | | | | | $ 121,213 | | | | | | $ — | | | | | | $ 660,577 | | |
负债 | | | | | | | | | | | | | | | | | | | | | | | | | |
或有对价
|
| | | | $ — | | | | | | $ — | | | | | | $ 5,716 | | | | | | $ 5,716 | | |
| | |
2020
|
| |||||||||||||||||||||
| | |
一级
|
| |
二级
|
| |
第三级
|
| |
合计
|
| ||||||||||||
现金等价物
|
| | | | $ 222 | | | | | | $ — | | | | | | $ — | | | | | | $ 222 | | |
持有至到期: | | | | | | | | | | | | | | | | | | | | | | | | | |
美国政府和机构的义务
|
| | | | 6,732 | | | | | | — | | | | | | — | | | | | | 6,732 | | |
存单
|
| | | | — | | | | | | 1,119 | | | | | | — | | | | | | 1,119 | | |
持有至到期的合计
|
| | | | $ 6,954 | | | | | | $ 1,119 | | | | | | $ — | | | | | | $ 8,073 | | |
| | |
2019
|
| |||||||||||||||||||||
| | |
一级
|
| |
二级
|
| |
第三级
|
| |
合计
|
| ||||||||||||
持有至到期: | | | | | | | | | | | | | | | | | | | | | | | | | |
美国政府和机构的义务
|
| | | | $ 5,577 | | | | | | $ — | | | | | | $ — | | | | | | $ 5,577 | | |
存单
|
| | | | — | | | | | | 1,191 | | | | | | — | | | | | | 1,191 | | |
持有至到期的合计
|
| | | | $ 5,577 | | | | | | $ 1,191 | | | | | | $ — | | | | | | $ 6,768 | | |
| | |
2020
|
| |
2019
|
| ||||||
软件 | | | | | $ 13,202 | | | | | | $ 3,235 | | |
租赁改进
|
| | | | 3,604 | | | | | | 2,331 | | |
医疗设备
|
| | | | 705 | | | | | | 33 | | |
总物业和设备
|
| | | | 17,511 | | | | | | 5,599 | | |
减去累计折旧
|
| | | | (5,247) | | | | | | (2,368) | | |
财产和设备,净额
|
| | | | $ 12,264 | | | | | | $ 3,231 | | |
| | |
光明医疗
|
| |
NeueHealth
|
| ||||||||||||||||||
| | |
毛收入
金额 |
| |
累计
减损 |
| |
毛收入
金额 |
| |
累计
减损 |
| ||||||||||||
2019年1月1日的余额
|
| | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | |
收购
|
| | | | — | | | | | | — | | | | | | 20,125 | | | | | | — | | |
2019年12月31日的余额
|
| | | | — | | | | | | — | | | | | | 20,125 | | | | | | — | | |
收购
|
| | | | 197,886 | | | | | | | | | | | | 45,142 | | | | | | | | |
采购调整
|
| | | | — | | | | | | — | | | | | | (118) | | | | | | — | | |
2020年12月31日的余额
|
| | | $ | 197,886 | | | | | $ | — | | | | | $ | 65,149 | | | | | $ | — | | |
| | |
2020年12月31日
|
| |
2019年12月31日
|
| ||||||||||||||||||
| | |
毛收入
金额 |
| |
累计
摊销 |
| |
毛收入
金额 |
| |
累计
摊销 |
| ||||||||||||
客户关系
|
| | | | $ 117,451 | | | | | | $ 3,664 | | | | | | $ 11,251 | | | | | | $ — | | |
商品名称
|
| | | | 38,161 | | | | | | 1,604 | | | | | | 7,461 | | | | | | — | | |
其他 | | | | | 2,000 | | | | | | 133 | | | | | | — | | | | | | — | | |
合计 | | | | | $ 157,612 | | | | | | $ 5,401 | | | | | | $ 18,712 | | | | | | $ — | | |
| | |
2020
|
| |
2019
|
| ||||||||||||||||||
| | |
公允价值
|
| |
加权-
平均有用 寿命(以年为单位) |
| |
公允价值
|
| |
加权-
平均有用 寿命(以年为单位) |
| ||||||||||||
客户关系
|
| | | | $ 106,200 | | | | | | 10.6 | | | | | | $ 11,251 | | | | | | 10.0 | | |
商品名称
|
| | | | 30,700 | | | | | | 15.0 | | | | | | 7,461 | | | | | | 15.0 | | |
其他 | | | | | 2,000 | | | | | | 10.0 | | | | | | — | | | | | | — | | |
合计 | | | | | $ 138,900 | | | | | | 11.6 | | | | | | $ 18,712 | | | | | | 12.0 | | |
| | |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
1月1日 - 应付医疗费用
|
| | | | $ 44,804 | | | | | | $ 22,978 | | | | | | $ 5,845 | | |
发生的费用与:
|
| | | | | | | | | | | | | | |||||
本年度
|
| | | | 1,057,064 | | | | | | 233,447 | | | | | | 97,587 | | |
上一年
|
| | | | (8,622) | | | | | | (7,427) | | | | | | (1,181) | | |
已发生的总费用
|
| | | | 1,048,442 | | | | | | 226,020 | | | | | | (96,406) | | |
付款对象:
|
| | | | | | | | | | | | | | |||||
本年度
|
| | | | 941,401 | | | | | | 188,919 | | | | | | 74,750 | | |
上一年
|
| | | | 33,479 | | | | | | 15,275 | | | | | | 4,523 | | |
支付总额
|
| | | | 974,880 | | | | | | 204,194 | | | | | | 79,273 | | |
获得的索赔负债
|
| | | | 131,411 | | | | | | — | | | | | | — | | |
12月31日 - 应付医疗费用
|
| | | | $ 249,777 | | | | | | $ 44,804 | | | | | | $ 22,978 | | |
| | |
2020
|
| |
2019
|
| ||||||
未付索赔
|
| | | | $ 23,269 | | | | | | $ 3,245 | | |
应付风险分担金额
|
| | | | 16,963 | | | | | | 3,572 | | |
索赔调整费用负债
|
| | | | 2,487 | | | | | | 1,345 | | |
已发生但未报告(IBNR)
|
| | | | 207,058 | | | | | | 36,642 | | |
应付医疗费用总额
|
| | | | $ 249,777 | | | | | | $ 44,804 | | |
| | |
已发生索赔和已分配索赔调整
费用,扣除再保险后的净额(千) |
| |
已发生的总费用,但
未报告 负债加 预期 在 上的开发 已报告索赔 |
| ||||||||||||||||||
| | |
截至2013年12月31日的年度
|
| |||||||||||||||||||||
事故年份
|
| |
(未审核)
2018 |
| |
(未审核)
2019 |
| |
2020
|
| |||||||||||||||
2018 | | | | | 435,729 | | | | | | 435,230 | | | | | | 436,786 | | | | | | 41 | | |
2019 | | | | | — | | | | | | 733,216 | | | | | | 724,120 | | | | | | 1,321 | | |
2020 | | | | | — | | | | | | — | | | | | | 1,303,467 | | | | | | 244,593 | | |
合计
|
| | | | | | | | | | | | | | | | $ 2,464,373 | | | | | | | | |
| | |
累计已支付索赔和已分配索赔调整
费用,扣除再保险后的净额(千) |
| |||||||||||||||
| | |
截至2013年12月31日的年度
|
| |||||||||||||||
事故年份
|
| |
(未审核)
2018 |
| |
(未审核)
2019 |
| |
2020
|
| |||||||||
2018 | | | | | 366,558 | | | | | | 435,065 | | | | | | 436,882 | | |
2019 | | | | | — | | | | | | 620,495 | | | | | | 717,624 | | |
2020 | | | | | — | | | | | | — | | | | | | 1,065,531 | | |
合计
|
| | | | | | | | | | | | | | | | $ 2,220,037 | | |
2018年前所有未偿负债,扣除再保险后的净额
|
| | | | | | | | | | | | | | | | 121 | | |
扣除再保险后的理赔和理赔费用负债
|
| | | | | | | | | | | | | | | | $ 244,457 | | |
| | |
2020年12月31日
|
| |||
未偿债务净额
|
| | | | $ 244,457 | | |
未付索赔可获再保险
|
| | | | 5,320 | | |
未付索赔和索赔的总负债
|
| | | | $ 249,777 | | |
优先股系列
|
| |
首选
个共享 授权 |
| |
首选
个共享 已发布 |
| |
首选
个共享 出色的 |
| |
携带
值 |
| |
清算
首选项 |
| |
普通股
可于 签发 转换 |
| ||||||||||||||||||
A | | | | | 32,439 | | | | | | 32,439 | | | | | | 32,439 | | | | | | $ 81,690 | | | | | | $ 82,718 | | | | | | 22,018 | | |
B | | | | | 32,278 | | | | | | 32,278 | | | | | | 32,278 | | | | | | 163,000 | | | | | | 163,000 | | | | | | 96,834 | | |
C | | | | | 26,065 | | | | | | 26,065 | | | | | | 26,065 | | | | | | 200,000 | | | | | | 200,000 | | | | | | 78,196 | | |
D | | | | | 48,101 | | | | | | 48,101 | | | | | | 48,101 | | | | | | 718,500 | | | | | | 722,710 | | | | | | 144,304 | | |
E | | | | | 27,424 | | | | | | 25,362 | | | | | | 25,362 | | | | | | 517,825 | | | | | | 517,825 | | | | | | 76,085 | | |
合计 | | | | | 166,307 | | | | | | 164,245 | | | | | | 164,245 | | | | | | $ 1,681,015 | | | | | | $ 1,686,253 | | | | | | 417,437 | | |
优先股系列
|
| |
首选
个共享 授权 |
| |
首选
个共享 已发布 |
| |
首选
个共享 出色的 |
| |
携带
值 |
| |
清算
首选项 |
| |
普通股
可于 签发 转换 |
| ||||||||||||||||||
A | | | | | 39,778 | | | | | | 32,439 | | | | | | 32,439 | | | | | | $ 81,690 | | | | | | $ 82,718 | | | | | | 22,018 | | |
B | | | | | 32,278 | | | | | | 32,278 | | | | | | 32,278 | | | | | | 163,000 | | | | | | 163,000 | | | | | | 96,834 | | |
C | | | | | 26,065 | | | | | | 26,065 | | | | | | 26,065 | | | | | | 200,000 | | | | | | 200,000 | | | | | | 78,196 | | |
D | | | | | 54,757 | | | | | | 28,440 | | | | | | 28,440 | | | | | | 427,300 | | | | | | 427,300 | | | | | | 85,319 | | |
合计 | | | | | 152,878 | | | | | | 119,222 | | | | | | 119,222 | | | | | | $ 871,990 | | | | | | $ 873,018 | | | | | | 282,367 | | |
| | |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
无风险利率
|
| | | | 0.88% | | | | | | 2.22% | | | | | | 2.75% | | |
预期波动率
|
| | | | 31.3% | | | | | | 28.3% | | | | | | 28.5% | | |
预期股息率
|
| | | | 0.0% | | | | | | 0.0% | | | | | | 0.0% | | |
失败率
|
| | | | 14.5% | | | | | | 14.5% | | | | | | 14.5% | | |
预期寿命(以年为单位)
|
| | | | 6.1 | | | | | | 6.1 | | | | | | 6.1 | | |
| | |
个共享
|
| |
加权-
平均 练习 价格 |
| |
加权平均
剩余 合同期限 (年) |
| |
聚合
内在价值 |
| ||||||||||||
2020年1月1日业绩突出
|
| | | | 37,872 | | | | | | 1.06 | | | | | | 9.0 | | | | | | $ 27,065 | | |
已批准
|
| | | | 30,975 | | | | | | 1.90 | | | | | | | | | | | | | | |
锻炼
|
| | | | (2,154) | | | | | | 0.74 | | | | | | | | | | | | | | |
被没收
|
| | | | (2,731) | | | | | | 1.24 | | | | | | | | | | | | | | |
已过期
|
| | | | (37) | | | | | | 1.02 | | | | | | | | | | | | | | |
2020年12月31日业绩突出
|
| | | | 63,925 | | | | | | $ 1.47 | | | | | | 8.7 | | | | | | $ 53,573 | | |
| | |
个共享
|
| |
加权平均
授予日期 公允价值 每股 |
| ||||||
RSA于2020年1月1日解除授权
|
| | | | 291 | | | | | | 0.01 | | |
本年度授予的RSA
|
| | | | — | | | | | | — | | |
本年度RSA已取消
|
| | | | — | | | | | | — | | |
本年度内归属的RSA
|
| | | | (291) | | | | | | 0.01 | | |
RSA于2020年12月31日解除授权
|
| | | | — | | | | | | $ — | | |
| | |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
净亏损
|
| | | | $ (248,442) | | | | | | $ (125,337) | | | | | | $ (62,641) | | |
加权平均流通股数量用于计算
普通股股东每股净亏损,基本股和 稀释 |
| | | | 136,193 | | | | | | 134,486 | | | | | | 131,975 | | |
普通股股东每股基本和摊薄净亏损
|
| | | | $ (1.82) | | | | | | $ (0.93) | | | | | | $ (0.47) | | |
| | |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
可赎回优先股
|
| | | | 417,437 | | | | | | 282,367 | | | | | | 197,047 | | |
购买普通股的股票期权
|
| | | | 63,925 | | | | | | 37,872 | | | | | | 12,719 | | |
合计 | | | | | 481,362 | | | | | | 320,239 | | | | | | 209,766 | | |
| | |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
当前 | | | | | $ — | | | | | | $ — | | | | | | $ — | | |
延期 | | | | | (9,161) | | | | | | — | | | | | | — | | |
所得税(福利)总费用
|
| | | | $ (9,161) | | | | | | $ — | | | | | | $ — | | |
| | |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
按联邦法定税率计算的税收(福利)费用
|
| | | | $ (52,173) | | | | | | $ (26,321) | | | | | | $ (13,155) | | |
因以下原因增加(减少)所得税: | | | | | | | | | | | | | | | | | | | |
调整递延税额估值免税额
|
| | | | 43,012 | | | | | | 26,321 | | | | | | 13,155 | | |
所得税(福利)费用
|
| | | | $ (9,161) | | | | | | $ — | | | | | | $ — | | |
实际税率
|
| | | | 3.6% | | | | | | 0.0% | | | | | | 0.0% | | |
| | |
2020
|
| |
2019
|
| ||||||
递延税金资产: | | | | | | | | | | | | | |
净营业亏损结转
|
| | | | $ 107,002 | | | | | | $ 53,325 | | |
预收保费
|
| | | | 1,454 | | | | | | 672 | | |
应计工资和福利
|
| | | | 5,246 | | | | | | 1,557 | | |
第195节启动费用
|
| | | | 2,164 | | | | | | 2,364 | | |
其他
|
| | | | 1,173 | | | | | | 371 | | |
| | | | | 117,039 | | | | | | 58,289 | | |
减去估值免税额
|
| | | | (99,537) | | | | | | (57,491) | | |
递延税金资产总额
|
| | | | 17,502 | | | | | | 798 | | |
递延纳税义务: | | | | | | | | | | | | | |
预付费用
|
| | | | (1,195) | | | | | | (373) | | |
固定资产
|
| | | | (628) | | | | | | (151) | | |
商誉和无形资产
|
| | | | (15,447) | | | | | | — | | |
未实现收益
|
| | | | (509) | | | | | | — | | |
投资收益
|
| | | | (3) | | | | | | (274) | | |
递延纳税负债总额
|
| | | | (17,782) | | | | | | (798) | | |
递延纳税净负债
|
| | | | $ (280) | | | | | | $ — | | |
| | |
资产负债表位置
|
| |
2020
|
| |
2019
|
| |||||||||
资产 | | | | | | | | | | | | | | | | | | | |
经营租赁ROU资产
|
| | | | 其他非流动资产 | | | | | | $ 26,965 | | | | | | $ 14,028 | | |
负债 | | | | | | | | | | | | | | | | | | | |
经营租赁负债 - 流动
|
| | | | 其他当前负债 | | | | | | 6,569 | | | | | | 3,520 | | |
营业租赁负债 - 非流动
|
| | | | 其他负债 | | | | | | 21,851 | | | | | | 10,950 | | |
租赁总负债
|
| | | | | | | | | | $ 28,420 | | | | | | $ 14,470 | | |
| | |
2020
|
| |
2019
|
| ||||||
营业租赁的营业现金流
|
| | | | $ 6,131 | | | | | | $ 1,998 | | |
以新租赁负债换取的ROU资产
|
| | | | 7,793 | | | | | | 274 | | |
收购获得的ROU资产
|
| | | | 8,392 | | | | | | 3,925 | | |
加权-平均剩余租赁年限(单位:年)
|
| | | | 5.6 | | | | | | 5.2 | | |
加权平均贴现率
|
| | | | 6.0% | | | | | | 6.0% | | |
| | |
最低租赁
付款 |
| |||
截至2013年12月31日的年份: | | | | | | | |
2021
|
| | | | $ 7,356 | | |
2022
|
| | | | 6,692 | | |
2023
|
| | | | 5,409 | | |
2024
|
| | | | 4,858 | | |
2025
|
| | | | 3,553 | | |
此后
|
| | | | 6,073 | | |
未打折的未来最低还款额
|
| | | | 33,941 | | |
计入利息
|
| | | | (5,521) | | |
报告的租赁负债总额
|
| | | | $ 28,420 | | |
| | |
明亮
医疗保健 |
| |
NeueHealth
|
| |
消除
|
| |
合并
|
| ||||||||||||
保费收入
|
| | | | $ 1,172,545 | | | | | | $ 7,793 | | | | | | $ — | | | | | | $1,180,338 | | |
服务收入
|
| | | | — | | | | | | 18,514 | | | | | | — | | | | | | 18,514 | | |
投资收益
|
| | | | 8,468 | | | | | | — | | | | | | — | | | | | | 8,468 | | |
无关联总收入
|
| | | | 1,181,013 | | | | | | 26,307 | | | | | | — | | | | | | 1,207,320 | | |
关联收入
|
| | | | — | | | | | | 10,840 | | | | | | (10,840) | | | | | | — | | |
部门总收入
|
| | | | 1,181,013 | | | | | | 37,147 | | | | | | (10,840) | | | | | | 1,207,320 | | |
所得税前亏损
|
| | | | (248,896) | | | | | | (8,707) | | | | | | — | | | | | | (257,603) | | |
折旧摊销
|
| | | | $ 6,394 | | | | | | $ 1,895 | | | | | | $ — | | | | | | $ 8,289 | | |
| | |
可赎回
非控制性 利息 |
| |||
2020年1月1日的余额
|
| | | | $ — | | |
收购
|
| | | | 39,600 | | |
2020年12月31日的余额
|
| | | | $ 39,600 | | |
| | |
截至2013年12月31日的年度
|
| |||||||||||||||
| | |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
收入: | | | | | | | | | | | | | | | | | | | |
投资收益
|
| | | | 26 | | | | | | 16 | | | | | | 8 | | |
总收入
|
| | | | 26 | | | | | | 16 | | | | | | 8 | | |
运营成本: | | | | | | | | | | | | | | | | | | | |
运营成本
|
| | | | 5,867 | | | | | | 2,194 | | | | | | 892 | | |
总运营成本
|
| | | | 5,867 | | | | | | 2,194 | | | | | | 892 | | |
子公司净亏损中的所得税和权益前亏损
|
| | | | (5,841) | | | | | | (2,178) | | | | | | (884) | | |
所得税(福利)费用
|
| | | | — | | | | | | (123) | | | | | | (151) | | |
子公司净亏损中的权益前亏损
|
| | | | (5,841) | | | | | | (2,055) | | | | | | (733) | | |
子公司净亏损权益
|
| | | | (242,601) | | | | | | (123,282) | | | | | | (61,908) | | |
净亏损
|
| | | | (248,442) | | | | | | (125,337) | | | | | | (62,641) | | |
未实现的投资持股收益
|
| | | | 1,556 | | | | | | 1,211 | | | | | | 72 | | |
减去:投资损益重新分类调整
|
| | | | 112 | | | | | | 38 | | | | | | (17) | | |
其他综合收益
|
| | | | 1,444 | | | | | | 1,173 | | | | | | 89 | | |
全面亏损
|
| | | | $ (246,998) | | | | | | $ (124,164) | | | | | | $ (62,552) | | |
| | |
截至12月31日
|
| |||||||||
| | |
2020
|
| |
2019
|
| ||||||
资产 | | | | | | | | | | | | | |
流动资产: | | | | | | | | | | | | | |
现金和现金等价物
|
| | | | $ 1,708 | | | | | | $ 563 | | |
短期投资
|
| | | | 1,119 | | | | | | 1,191 | | |
子公司投资
|
| | | | 1,172,126 | | | | | | 605,702 | | |
关联方应收账款净额
|
| | | | — | | | | | | 123 | | |
其他资产
|
| | | | 64 | | | | | | 62 | | |
总资产
|
| | | | 1,175,017 | | | | | | 607,641 | | |
负债、可赎回优先股和股东亏损 | | | | | | | | | | | | | |
关联方应付,净额
|
| | | | 100 | | | | | | — | | |
承付款和或有事项(附注14) | | | | | | | | | | | | | |
可赎回优先股,面值0.0001美元;2020年和2019年分别授权的166,307,087股和152,878,225股;2020年和2019年分别发行和发行的164,244,893股和119,221,767股
|
| | | | 1,681,015 | | | | | | 871,990 | | |
股东权益(亏损): | | | | | | | | | | | | | |
普通股,面值0.0001美元;2020年和2019年分别授权658,993,725股和563,612,706股;2020年和2019年分别发行和发行137,662,698股和135,509,085股
|
| | | | 14 | | | | | | 14 | | |
新增实收资本
|
| | | | 9,877 | | | | | | 3,184 | | |
留存收益(亏损)
|
| | | | (515,989) | | | | | | (267,547) | | |
股东亏损总额
|
| | | | (506,098) | | | | | | (264,349) | | |
总负债、可赎回优先股和股东亏损
|
| | | | $ 1,175,017 | | | | | | $ 607,641 | | |
| | |
截至2013年12月31日的年度
|
| |||||||||||||||
| | |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
经营活动使用的净现金
|
| | | | (168) | | | | | | (557) | | | | | | (284) | | |
投资活动现金流: | | | | | | | | | | | | | | | | | | | |
购买投资
|
| | | | (1,119) | | | | | | (1,191) | | | | | | (455) | | |
投资的销售、支付和到期日收益
|
| | | | 1,191 | | | | | | 455 | | | | | | 1,727 | | |
对运营子公司的出资
|
| | | | (480,869) | | | | | | (390,945) | | | | | | (204,300) | | |
业务收购,扣除收购现金后的净额
|
| | | | (230,331) | | | | | | (31,855) | | | | | | — | | |
投资活动使用的净现金
|
| | | | (711,128) | | | | | | (423,536) | | | | | | (203,028) | | |
融资活动现金流: | | | | | | | | | | | | | | | | | | | |
普通股发行收益
|
| | | | 1,241 | | | | | | 260 | | | | | | 57 | | |
优先股发行收益
|
| | | | 711,200 | | | | | | 423,800 | | | | | | 203,000 | | |
融资活动提供的净现金
|
| | | | 712,441 | | | | | | 424,060 | | | | | | 203,057 | | |
现金和现金等价物净增长
|
| | | | 1,145 | | | | | | (33) | | | | | | (255) | | |
年初 - 现金和现金等价物
|
| | | | 563 | | | | | | 596 | | | | | | 851 | | |
现金和现金等价物 - 年终
|
| | | | $ 1,708 | | | | | | $ 563 | | | | | | $ 596 | | |
| | |
THNM
|
| |
Zipnosis
|
| ||||||
现金和现金等价物
|
| | | | $ 24,059 | | | | | | $ 3,194 | | |
应收账款
|
| | | | 714 | | | | | | 1,062 | | |
短期投资
|
| | | | 4,677 | | | | | | — | | |
预付和其他流动资产
|
| | | | 8,337 | | | | | | 141 | | |
物业和设备
|
| | | | — | | | | | | 232 | | |
无形资产
|
| | | | 8,250 | | | | | | 8,580 | | |
长期投资
|
| | | | 13,081 | | | | | | — | | |
其他非流动资产
|
| | | | 1,324 | | | | | | 766 | | |
总资产
|
| | | | 60,442 | | | | | | 13,975 | | |
应付医疗费用
|
| | | | 13,268 | | | | | | — | | |
应付帐款
|
| | | | 14,663 | | | | | | 136 | | |
其他流动负债
|
| | | | 6,327 | | | | | | 785 | | |
其他负债
|
| | | | 993 | | | | | | 1,998 | | |
总负债
|
| | | | 35,251 | | | | | | 2,919 | | |
已确认净资产收购
|
| | | | 25,191 | | | | | | 11,056 | | |
商誉
|
| | | | 2,282 | | | | | | 46,180 | | |
总购买考量
|
| | | | $ 27,473 | | | | | | $ 57,236 | | |
| | |
形式合并
损益表 (未审核) |
| |||||||||
| | |
2020
|
| |
2019
|
| ||||||
收入 | | | | | | | | | | | | | |
THNM
|
| | | | $ 1,325,584 | | | | | | $ 453,973 | | |
Zipnosis
|
| | | | $ 1,217,899 | | | | | | $ 287,167 | | |
净亏损 | | | | | | | | | | | | | |
THNM
|
| | | | $ (255,805) | | | | | | $ (121,887) | | |
Zipnosis
|
| | | | $ (251,660) | | | | | | $ (129,164) | | |
| | |
截至4月30日
2020 |
| |||
资产 | | | | | | | |
流动资产: | | | | | | | |
现金
|
| | |
|
$ 2,500
|
| |
保费和风险调整应收账款
|
| | |
|
74,578
|
| |
其他应收账款
|
| | |
|
25,162
|
| |
预付和其他资产
|
| | |
|
4,971
|
| |
流动资产总额
|
| | | | 107,211 | | |
其他资产: | | | | | | | |
受限现金
|
| | |
|
359
|
| |
物业、厂房和设备,净额
|
| | |
|
4,375
|
| |
其他应收账款
|
| | |
|
350
|
| |
存款和其他资产
|
| | |
|
176
|
| |
其他资产合计
|
| | | | 5,260 | | |
总资产
|
| | | | $ 112,471 | | |
负债和股东赤字 | | | | | | | |
流动负债: | | | | | | | |
应付医疗索赔
|
| | |
|
$ 90,118
|
| |
风险分担安排
|
| | |
|
31,152
|
| |
应计费用
|
| | |
|
36,074
|
| |
应付帐款
|
| | |
|
2,354
|
| |
应计工资总额及相关负债
|
| | |
|
1,688
|
| |
流动负债总额
|
| | | | 161,386 | | |
附属应付票据 - 关联方
|
| | |
|
33,000
|
| |
总负债
|
| | | | 194,386 | | |
股东亏损 | | | | | | | |
普通股:
|
| | | | | | |
A-1类,无面值,授权45万股,已发行10万股,
未偿还的 |
| | |
|
—
|
| |
A-2类,无面值,授权45万股,已发行10万股,
未偿还的 |
| | |
|
—
|
| |
B类,无面值,100,000股授权,4500股已发行和已发行
|
| | |
|
—
|
| |
新增实收资本
|
| | |
|
13,322
|
| |
累计亏损
|
| | |
|
(95,237)
|
| |
股东亏损总额
|
| | | | (81,915) | | |
总负债和股东赤字
|
| | | | $ 112,471 | | |
| | |
十个月
已结束 04月30日 2020 |
| |||
收入 | | | | | | | |
医疗保险费
|
| | |
|
$ 446,381
|
| |
Medi-Cal保费
|
| | |
|
370
|
| |
其他收入
|
| | |
|
109
|
| |
总收入
|
| | | | 446,860 | | |
费用 | | | | | | | |
医疗服务
|
| | |
|
434,607
|
| |
为附属公司提供的医疗服务
|
| | |
|
2,620
|
| |
营销、一般和行政费用
|
| | |
|
47,906
|
| |
工资福利
|
| | |
|
15,467
|
| |
折旧摊销
|
| | |
|
1,293
|
| |
利息费用净额
|
| | |
|
1,312
|
| |
其他费用
|
| | |
|
4
|
| |
总费用
|
| | | | 503,209 | | |
税前亏损
|
| | | | (56,349) | | |
所得税(福利)费用
|
| | | | 1 | | |
净亏损
|
| | | | $ (56,350) | | |
| | |
A-1类
普通股 |
| |
A-2类
普通股 |
| |
B类
普通股 |
| |
其他
实收 大写 |
| |
累计
赤字 |
| |
合计
|
| ||||||||||||||||||||||||||||||||||||
| | |
个共享
|
| |
金额
|
| |
个共享
|
| |
金额
|
| |
个共享
|
| |
金额
|
| ||||||||||||||||||||||||||||||||||||
2019年6月30日的余额
|
| | | | 100,000 | | | | | | — | | | | | | 100,000 | | | | | | — | | | | | | 4,500 | | | | | | — | | | | | | 13,322 | | | | | | (38,887) | | | | | | (25,565) | | |
净亏损
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (56,350) | | | | | | (56,350) | | |
2020年4月30日的余额
|
| | | | 100,000 | | | | | | — | | | | | | 100,000 | | | | | | — | | | | | | 4,500 | | | | | | — | | | | | | 13,322 | | | | | | (95,237) | | | | | | (81,915) | | |
| | |
十个月
已结束 04月30日 2020 |
| |||
经营活动的现金流 | | | | | | | |
净亏损
|
| | |
|
$ (56,350)
|
| |
将净亏损与经营活动提供的净现金和限制性现金(用于)进行调整:
|
| | | | | | |
折旧摊销
|
| | |
|
1,293
|
| |
设备处置损失
|
| | |
|
4
|
| |
资产负债变动:
|
| | | | | | |
保费和风险调整应收账款
|
| | |
|
(28,920)
|
| |
其他应收账款
|
| | |
|
(11,263)
|
| |
预付和其他资产
|
| | |
|
11,444
|
| |
存款和其他资产
|
| | |
|
411
|
| |
应付医疗索赔
|
| | |
|
27,357
|
| |
风险分担安排
|
| | |
|
14,701
|
| |
应计费用
|
| | |
|
34,186
|
| |
应付帐款
|
| | |
|
(322)
|
| |
应计工资总额及相关负债
|
| | |
|
237
|
| |
未赚取保费
|
| | |
|
(41,541)
|
| |
经营活动中使用的净现金和限制性现金
|
| | |
|
(48,763)
|
| |
投资活动产生的现金流 | | | | | | | |
购置房产、厂房和设备
|
| | |
|
(2,600)
|
| |
投资活动中使用的净现金和限制性现金
|
| | |
|
(2,600)
|
| |
融资活动产生的现金流
|
| | | | | | |
附属应付票据 - 关联方收益
|
| | |
|
8,000
|
| |
融资活动提供的净现金和限制性现金
|
| | |
|
8,000
|
| |
现金和限制性现金净变化
|
| | | | (43,363) | | |
现金和限制性现金,年初
|
| | | | 46,222 | | |
现金和受限现金,期末
|
| | | | $ 2,859 | | |
补充披露信息: | | | | | | | |
利息期间支付的 现金
|
| | |
|
$ 1,366
|
| |
| | |
截至4月30日
2020 |
| |||
现金
|
| | |
|
$ 2,500
|
| |
受限现金
|
| | |
|
359
|
| |
现金流量表上显示的现金总额和限制性现金
|
| | |
|
$ 2,859
|
| |
| | |
预计寿命
|
|
建筑物和装修设备 | | |
5年至30年
|
|
设备 | | |
5到7年
|
|
租赁改进 | | |
资产的不可取消租赁期限或独特使用寿命较短
|
|
家具和固定装置 | | |
5年
|
|
计算机和软件 | | |
3至4年
|
|
| | |
截至4月30日
2020 |
| |||
CMS风险调整 - 部件C
|
| | |
|
$ 71,292
|
| |
CMS风险调整 - 部件D
|
| | |
|
2,748
|
| |
HealthNet SPD调整
|
| | |
|
450
|
| |
CMS医疗费AR
|
| | |
|
88
|
| |
合计
|
| | |
|
$ 74,578
|
| |
| | |
截至4月30日
2020 |
| |||
当前其他应收账款 | | | |||||
药房返点
|
| | |
|
$ 18,211
|
| |
提供商IBNR应收账款
|
| | |
|
4,490
|
| |
供应商应付款
|
| | |
|
1,697
|
| |
保险结算
|
| | |
|
764
|
| |
当期其他应收账款合计
|
| | |
|
25,162
|
| |
非当期担保第三方应收票据(1)
|
| | |
|
350
|
| |
合计
|
| | |
|
$ 25,512
|
| |
| | |
截至4月30日
2020 |
| |||
广告和销售佣金
|
| | |
|
$ 3,641
|
| |
延期收费
|
| | |
|
790
|
| |
其他
|
| | |
|
540
|
| |
合计
|
| | |
|
$ 4,971
|
| |
| | |
截至4月30日
2020 |
| |||
设备
|
| | |
|
$ 5,973
|
| |
家具和固定装置
|
| | |
|
573
|
| |
租赁改进
|
| | |
|
567
|
| |
计算机硬件和软件
|
| | |
|
7,199
|
| |
全部物业、厂房和设备
|
| | |
|
14,312
|
| |
减去:累计折旧摊销
|
| | |
|
(9,937)
|
| |
合计
|
| | |
|
$ 4,375
|
| |
| | |
截至4月30日
2020 |
| |||
IBNR期初余额
|
| | |
|
$ 55,749
|
| |
发生的费用与: | | | | | | | |
本期
|
| | |
|
184,012
|
| |
前期
|
| | |
|
11,245
|
| |
| | | | | 195,257 | | |
付款对象: | | | | | | | |
本期
|
| | |
|
(159,878)
|
| |
前期
|
| | |
|
(25,440)
|
| |
| | | | | (185,318) | | |
IBNR期末余额
|
| | |
|
65,688
|
| |
应付索赔、风险分担和其他准备金
|
| | |
|
24,430
|
| |
合计
|
| | |
|
$ 90,118
|
| |
| | |
截至4月30日
2020 |
| |||
UCAP本票
|
| | |
|
$ 16,500
|
| |
家庭笔记
|
| | |
|
16,500
|
| |
合计
|
| | |
|
$ 33,000
|
| |
截至4月30日
|
| |
合计
|
| |||
2020年剩余时间
|
| | | | $ 204 | | |
2021
|
| | | | 1,250 | | |
2022
|
| | | | 1,188 | | |
合计
|
| | | | $ 2,642 | | |
| | |
截至6月30日
2019 |
| |||
资产 | | | | | | | |
流动资产: | | | | | | | |
现金
|
| | | | $ 45,870 | | |
保费和风险调整应收账款
|
| | | | 45,658 | | |
其他应收账款
|
| | | | 14,249 | | |
预付和其他资产
|
| | | | 16,415 | | |
流动资产总额
|
| | | | 122,192 | | |
其他资产: | | | | | | | |
受限现金
|
| | | | 352 | | |
物业、厂房和设备,净额
|
| | | | 3,072 | | |
存款和其他资产
|
| | | | 587 | | |
其他资产合计
|
| | | | 4,011 | | |
总资产
|
| | | | $ 126,203 | | |
负债和股东赤字 | | | | | | | |
流动负债: | | | | | | | |
应付医疗索赔
|
| | | | $ 62,761 | | |
风险分担安排
|
| | | | 16,451 | | |
应计费用
|
| | | | 1,888 | | |
应付帐款
|
| | | | 2,676 | | |
应计工资总额及相关负债
|
| | | | 1,451 | | |
未赚取保费
|
| | | | 41,541 | | |
流动负债总额
|
| | | | 126,768 | | |
附属应付票据 - 关联方
|
| | | | 25,000 | | |
总负债
|
| | | | 151,768 | | |
股东亏损 | | | | | | | |
普通股: | | | | | | | |
A-1类,无票面价值,45万股授权,10万股已发行和已发行
|
| | | | — | | |
A-2类,无票面价值,45万股授权,10万股已发行和已发行
|
| | | | — | | |
B类,无面值,100,000股授权,4500股已发行和已发行
|
| | | | — | | |
新增实收资本
|
| | | | 13,322 | | |
累计亏损
|
| | | | (38,887) | | |
股东亏损总额
|
| | | | (25,565) | | |
总负债和股东赤字
|
| | | | $ 126,203 | | |
| | |
年终
6月30日 2019 |
| |||
收入 | | | | | | | |
医疗保险费
|
| | | | $ 419,175 | | |
Medi-Cal保费
|
| | | | 520 | | |
其他收入
|
| | | | 83 | | |
总收入
|
| | | | 419,778 | | |
费用 | | | | | | | |
医疗服务
|
| | | | 371,480 | | |
为附属公司提供的医疗服务
|
| | | | 3,536 | | |
营销、一般和行政费用
|
| | | | 33,054 | | |
工资福利
|
| | | | 12,280 | | |
折旧摊销
|
| | | | 1,115 | | |
利息费用净额
|
| | | | 1,235 | | |
总费用
|
| | | | 422,700 | | |
持续经营税前亏损
|
| | | | (2,922) | | |
所得税费用
|
| | | | 1 | | |
持续运营亏损
|
| | | | (2,923) | | |
停止运营(注2) | | | | | | | |
HealthNet运营损失
|
| | | | (4,865) | | |
停产损失
|
| | | | (4,865) | | |
净亏损
|
| | | | $ (7,788) | | |
| | |
A-1类
普通股 |
| |
A-2类
普通股 |
| |
B类
普通股 |
| |
其他
实收 大写 |
| |
累计
赤字 |
| |
合计
|
| ||||||||||||||||||||||||||||||||||||
| | |
个共享
|
| |
金额
|
| |
个共享
|
| |
金额
|
| |
个共享
|
| |
金额
|
| ||||||||||||||||||||||||||||||||||||
2018年6月30日的余额
|
| | | | 100,000 | | | | | | $ — | | | | | | 100,000 | | | | | | $ — | | | | | | 4,500 | | | | | | $ — | | | | | | $ 13,322 | | | | | | $ (31,099) | | | | | | $ (17,777) | | |
净亏损
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (7,788) | | | | | | (7,788) | | |
2019年6月30日的余额
|
| | | | 100,000 | | | | | | $ — | | | | | | 100,000 | | | | | | $ — | | | | | | 4,500 | | | | | | $ — | | | | | | $ 13,322 | | | | | | $ (38,887) | | | | | | $ (25,565) | | |
| | |
年终
6月30日 2019 |
| |||
经营活动的现金流 | | | | | | | |
净亏损
|
| | | | $ (7,788) | | |
将净亏损与经营活动提供的净现金和限制性现金(用于)进行调整:
|
| | | | | | |
折旧摊销
|
| | | | 1,115 | | |
资产负债变动:
|
| | | | | | |
保费和风险调整应收账款
|
| | | | (19,746) | | |
其他应收账款
|
| | | | (3,985) | | |
预付和其他资产
|
| | | | (309) | | |
存款和其他资产
|
| | | | (270) | | |
应付医疗索赔
|
| | | | 20,165 | | |
风险分担安排
|
| | | | 6,382 | | |
应计费用
|
| | | | (2,028) | | |
应付帐款
|
| | | | 1,899 | | |
应计工资总额及相关负债
|
| | | | 254 | | |
未赚取保费
|
| | | | 13,739 | | |
经营活动提供的净现金
|
| | | | 9,428 | | |
投资活动产生的现金流 | | | | | | | |
购置房产、厂房和设备
|
| | | | (2,056) | | |
投资活动使用的净现金
|
| | | | (2,056) | | |
融资活动产生的现金流 | | | | | | | |
附属应付票据-关联方扣除付款后的收益
|
| | | | 10,000 | | |
融资活动提供的净现金
|
| | | | 10,000 | | |
现金和限制性现金净变化
|
| | | | 17,372 | | |
现金和限制性现金,年初
|
| | | | 28,850 | | |
现金和受限现金,期末
|
| | | | $ 46,222 | | |
补充披露信息: | | | | | | | |
年内支付的利息现金
|
| | | | $ 1,297 | | |
| | |
截至6月30日
2019 |
| |||
现金
|
| | |
|
$ 45,870
|
| |
受限现金
|
| | |
|
352
|
| |
现金流量表上显示的现金总额和限制性现金
|
| | |
|
$ 46,222
|
| |
| | |
预计寿命
|
|
建筑物和装修设备 | | |
5年至20年
|
|
设备 | | |
5到7年
|
|
租赁改进 | | | 剩余租赁年限或15年较短 | |
家具和固定装置 | | |
7到10年
|
|
计算机和软件 | | |
3至5年
|
|
| | |
截至6月30日
2019 |
| |||
收入: | | | | | | | |
总净收入
|
| | | | $ 6,488 | | |
费用: | | | | | | | |
医疗服务
|
| | | | 9,892 | | |
工资和福利
|
| | | | 1,068 | | |
其他费用
|
| | | | 393 | | |
总费用
|
| | | | 11,353 | | |
停产业务税前亏损
|
| | | | (4,865) | | |
税费
|
| | | | — | | |
营业报表中停产的总亏损
|
| | | | $ (4,865) | | |
| | |
截至6月30日
2019 |
| |||
CMS风险调整 - 部件C
|
| | | | $ 38,873 | | |
CMS风险调整 - 部件D
|
| | | | 5,084 | | |
HealthNet SPD调整
|
| | | | 1,188 | | |
中Cal字幕
|
| | | | 513 | | |
合计
|
| | | | $ 45,658 | | |
| | |
截至6月30日
2019 |
| |||
供应商应付款
|
| | | | $ 2,766 | | |
药房返点
|
| | | | 10,002 | | |
保险结算
|
| | | | 1,331 | | |
第三方应收票据担保(1)
|
| | | | 150 | | |
合计
|
| | | | $ 14,249 | | |
| | |
截至6月30日
2019 |
| |||
向提供商预付字幕费用
|
| | | | $ 9,671 | | |
广告和销售佣金
|
| | | | 3,833 | | |
延期收费
|
| | | | 704 | | |
其他
|
| | | | 2,793 | | |
合计
|
| | | | $ 17,002 | | |
| | |
截至6月30日
2019 |
| |||
设备
|
| | | | $ 5,762 | | |
家具和固定装置
|
| | | | 547 | | |
租赁改进
|
| | | | 353 | | |
计算机硬件和软件
|
| | | | 5,050 | | |
全部物业、厂房和设备
|
| | | | 11,712 | | |
减去:累计折旧摊销
|
| | | | 8,640 | | |
合计
|
| | | | $ 3,072 | | |
| | |
截至6月30日
2019 |
| |||
IBNR期初余额
|
| | | | $ 40,670 | | |
发生的费用与: | | | | | | | |
本期
|
| | | | 169,256 | | |
前期
|
| | | | (808) | | |
| | | | | 168,448 | | |
付款对象: | | | | | | | |
本期
|
| | | | (114,455) | | |
前期
|
| | | | (38,913) | | |
| | | | | (153,369) | | |
IBNR期末余额
|
| | | | 55,749 | | |
应付索赔、风险分担和其他准备金
|
| | | | 7,012 | | |
合计
|
| | | | $ 62,761 | | |
| | |
截至6月30日
2019 |
| |||
UCAP本票
|
| | | | $ 12,500 | | |
家庭笔记
|
| | | | 12,500 | | |
合计
|
| | | | $ 25,000 | | |
截至6月30日的年份
|
| |
合计
|
| |||
2020
|
| | | | $ 1,037 | | |
2021
|
| | | | 1,191 | | |
合计
|
| | | | $ 2,228 | | |
| | |
截至6月30日
2019 |
| |||
电流: | | | | | | | |
联邦政府
|
| | | | $ — | | |
状态
|
| | | | 1 | | |
| | | | | 1 | | |
延期: | | | | | | | |
联邦政府
|
| | | | (809) | | |
状态
|
| | | | (1,134) | | |
估值免税额
|
| | | | 1,943 | | |
| | | | | — | | |
所得税拨备
|
| | | | $ 1 | | |
| | |
截至6月30日
2019 |
| |||
联邦法定利率
|
| | | | 21.0% | | |
效果:
|
| | | | | | |
估值免税额变动
|
| | | | (17.9)% | | |
不可抵扣费用
|
| | | | (3.3)% | | |
其他
|
| | | | 0.2% | | |
税金拨备
|
| | | | 0.0% | | |
| | |
截至6月30日
2019 |
| |||
递延税金资产: | | | | | | | |
净营业亏损
|
| | | | $ 7,540 | | |
慈善捐款
|
| | | | 40 | | |
税收抵免
|
| | | | 97 | | |
应计费用
|
| | | | 171 | | |
延期租金
|
| | | | 2 | | |
州税
|
| | | | 272 | | |
递延税金资产总额
|
| | | | 8,122 | | |
减去:估值免税额
|
| | | | (7,680) | | |
递延税金资产总额
|
| | | | 442 | | |
递延纳税义务: | | | | | | | |
分期付款递延收益
|
| | | | — | | |
物业、厂房和设备
|
| | | | (400) | | |
州税
|
| | | | — | | |
预付费用
|
| | | | (42) | | |
递延纳税负债总额
|
| | | | (442) | | |
递延税金资产净额
|
| | | | $ — | | |
|
美国银行证券
|
| |
花旗集团
|
| |
风笛手
|
|
|
野村证券
|
| |
RBC资本市场
|
|